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1. 0 TECHNICAL HIGHLIGHTS 
The feasibility of the Passive Immunological Agglutination (PIA) 
system was examined using a myxovirus, adenovirus, echovirus, herpes- 
virus, coxsackievirus and one Mycoplasma species. The sensitivity of the 
PIA technique was compared with conventional as  say techniques for detecting 
the presence of infective organisms. With the exception of the mycoplasma, 
the PIA system was shown to be up to 100 times a s  sensitive as  the conven- 
tional assay system with a response time of 1-2 hours versus 2-14 days 
for the conventional methods, 
The specificity of the PIA system was shown to  be excellent f o r  the 
- agents tested. 
’ two groups of clinical specimens. 
The effectiveness of the PIA system was analyzed by testing 
i The f i rs t  group contained nine clinical 
specimens that were contractually required plus two additional specimens. 
Six of the required nine specimens were found to contain influenza A2 (HK) 
virus by the PIA method, and three proved to be negative. The additional 
two specimens were found to  contain the virus (by PIA). The second group 
contained four specimens that were contractually required plus 5 additional 
specimens. All  of the required four specimens gave a positive PIA test  for  
influenza. 
test for influenza. 
The additional 5 samples included one that gave a positive PIA 
The PIA technique was found to be superior to the conventional 
method for detecting the agents partly because of the much shorter total 
response time. 
under examination. 
Reagent stability was good for the seven months it was 
The production of high titered antibody and its subsequent attachment 
to polystyrene latex particles has increased the sensitivity of the PIA test  
for  mycoplasma from 500 cfu/ml to100 cfu/ml. 
Different readout systems were examined during the course of 
the program. 
re  adout: 
Three systems appeared most conducive to automating the 
) 
(1) an electronic particle connector 
(2) a light scattering system 
(3 )  and a microscope video computer system. 
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L 1  TASK SUMMARY 
Sys tem Properties 
Sensitivity : 
Myxovi r u s 
Herpesvirus 
Adenovirus 
C oxsac kievi r us 
Ec hovi r ug 
Mycoplasma 
ResDonse Time: 
Sensitized Beads 
Storage Stability 
Specificity 
Current Status 
100 EID 5o /ml* 
1 P F U / m l *  
3 TCIDgO/ml:: 
1 ID50/ml:k 
1 PFU/ml:: 
100 CFU/ml':' 
1 hour 
7 months tested 
High for all organisms 
tested 
Objectives 
10-100 EID 50/ml 
1-10 P F U / m l  
1-10 TCID50/ml 
1-10 ID50/ml 
1-10 P F U / m l  
10-100 CFU/ml 
1 hour 
1 year 
High specificity for all 
organisms 
Egg Infectious Dose, 5070 Response 
Plaque-Forming Uni t  o r  Pock-Forming Unit 
Tissue Culture Infectious Dose, 5070 Response 
" E1D50 - 
P F U  - 
TCID50- 
CFU - Colony Forming Units 
ID50- Infectious Dose (mouse), 5070 Response 
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2 . 0  INTRODUCTION 
The summary report on Aerojet-General Job No. 1366 is provided 
covering the period of June 19, 1969 to July 31, 1970. 
This program is directed towards the development of the techniques 
and reagents necessary to make both qualitative and quantitative deter- 
minations of the microbial ecology of a crew during extended space flight. 
The first phase of this task is the investigation of feasibility of an antigen/ 
antibody system utilizing the PIA (Passive Immune Agglutination) tech- 
nique. 
Investigations in recent years have shown that latex particles 
can be successfully used in agglutination tests for detection of various 
antigens and antibodies. 
Singer and Plotz, (l) who applied it for the serological diagnosis of 
rheumatoid arthritis. 
agglutination reactions. In the first ,  antigen attached to the latex 
particle is used to measure agglutination quantitatively in the presence 
of test se ra  or  other fluids. 
body attached to the particles t o  test for the presence of antigen in 
samples of u n k n o w  composition. 
The latex fixation technique was developed by 
Two approaches were used to study subsequent 
The second approach incorporates anti- 
In the second approach, two methods of protein uptake a r e  postu- 
lated: (1) protein is absorbed as a bimolecular layer where the second 
layer contains about half the number of molecules of protein as the first 
layer; ( 2 )  absorbed protein forms a random immobile film with the 
protein molecules oriented parallel to the latex surface. 
absorption in the latter case occurs in the interstices between molecules 
already absorbed, with the orientation of the secondary molecules now 
perpendicular to the plane of the styrene. 
Further 
Several modifications of the latex agglutination reaction have been 
,) studied on this contract but the basic reaction principle remains the same; 
i. e . ,  interaction of antigen and antibody in a particulatized (via latex 
spheres) suspension. The particles function to amplify the molecular 
interaction of antigens and antibodies to the level where the immuno- 
specific reaction can be more readily observed. 
particles a r e  a valuable, though simple, tool for detecting and quantitating 
In this sense, the latex 
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small amounts of either antigen or antibody in aqueous systems. 
The PIA system utilizes the polystyrene bead coated with 
antib od y . 
To prove the feasibility of this system a s  a means of carrying 
out the desired determinations, six agents were chosen as  model 
systems for  study. The agents chosen were: (1) a myxovirus, influenza 
4, Hong Kong variety; (2) an adenovirus, type Ad; ( 3 )  Herpesvirus 
hominis; (4) an echovirus, type 9; (5) a coxsackievirus, type A2; and 
(6) Mycoplasma pneumoniae. 
The test  agents selected provide an effective survey of the 
) respiratory and enteric viruses usually encountered, a s  well a s  a sur- 
vey of the usual cultural recovery techniques employed. 
The MEMS feasibility study has been divided into two main sections. 
The first section contains the results of the first 9 months technical 
effort. 
technical effort which was added on contractually as  a continuation. 
The second section contains the results of the last  three months 
The first section contains the results of the immunological agent 
propagation efforts used to conduct the feasibility study of the PIA technique, 
specificity examinations, reagent shelf life studies, and examination of nine 
NASA-supplied clinical samples. 
The second section examines the effect of improved antiserum 
preparations to influenza and mycoplasma. In addition, an examination 
was made of readout systems that could be used to  automate the PIA test. 
At present, conductometric or light scattering appear to be the method of 
choice. 
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3.0 TECHNICAL DISCUSSION FIRST 9 MONTHS 
3.1 SYSTEM SENSITIVITY 
The ultimate sensitivity of the PIA detection system is 
dependent on a number of factors: (1) the reaction rate between antigens 
and specific antibody t o  form stable complexes, (2) the amount of active 
antibody on the sensitized beads, (3) the concentration of sensitized 
particles, (4) the method of readout and (5) the amount of cross-reactivity. 
The sensitivity of the PIA system was studied with five viruses 
and one Mycoplasma. It was the purpose of this study to determine the 
feasibility of the PIA test for a selection of viruses that would represent 
~ a cross-section of viruses encountered during clinical testing. Our ’ results confirmed the excellent sensitivity of the PIA method. 
The PIA test procedure is detailed in Appendix B. 
3.1.1. COXSACKIEVIRUS, TYPE A2 
The detection of this virus presented some unusual problems 
because of the need for propagation of the virus in the brains of suckling 
mice. 
serum-saline solution for  use as antigen. The brains of normal suckling 
mice, processed identically, a r e  used a s  the controls for the PIA sensi- 
tivity examinations. 
this virus reflects the method of preparation of the antiserum received 
from NASA. 
infected suckling mouse carcasses  into rabbits. Thus, in addition to 
the antibody against the virus that was produced, there wre also large 
quantities of antibody against other mouse tissue antigens. 
antibody against mouse tissue that accounts for the high background level 
and standard deviation that i s  seen in the PIA sensitivity determinations with 
The brains a r e  harvested and homogenized in agamma horse 
The reason for the high control values obtained with 
Coxsackievirus antiserum was produced by injections of 
It may be 
) the coxsackievirus. 
In spite of the high background level, the sensitivity of the 
0 1 PIA test with the coxsackievirus appears to be on the order of 10 
ID5O/ml. 
40 experiments (detailed in Table 2 )  and represents the type of sensi- 
tivity one can expect with the materials currently available. Figure 1 
is a graphic representation of the average signal and noise data obtained 
in this system, a d  shows the formula for a best f i t  straight line. 
- 10 
Table 1 is a summary table of data obtained in approsimately 
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Table 1 
AVERAGE S - N  OF PIA DETERMINATIONS WITH THE C O X -  
SACKIEVIRUS AS MEASURED B Y  MEAN CLUMP SIZE 
Virus 
Concentration 
ID50/rnl* Signal (S) Noise (N) S-BI (. 
ID4 7.19 4.05 3.14 
lo3 7.01 4 . 3 5  2 . 6 6  
"1 
lo2 7.56 
lo1 6.42 
10 O 5.58 
Average Noise = 4.3 
Standard Deviation = 0. 79 
4.54 
4.79 
4 . 1 1  
3 . 0 2  
1. 63 
1.47 
~ ~~~ 
*Infectious Dose  
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TABLE 2 
PLA SENSITIVITY DETERMINATIONS 
COXSACKIEVIRUS AS DETERMINED BY MEAN CLUMP SIZE 
C ox s ae kiev ir u s Signal Noise 
Concentration Mean Clump Size Mean Clump Size 
ID5 / ml* (S 1 ( N) S-N 
1°4 
1°4 
2 1°4 
104 
lo 4 
::Infectious Dose 
I3 66 
5.90 
7.72 
7.15 
6.05 
6.13 
8.55 
5.08 
9.05 
7.60 
8.55 
7.70 
7.26 
6.79 
7.16 
6.60 
5.36 
5.18 
8.60 
7.30 
8.92 
7.48 
8.21 
4.84 
5.65 
9.04 
7.38 
8.40 
8.05 
8.99 
5.46 
8.32 
8.27 
4.97 
5.12 
6.07 
5; 40 
6.45 
4.40 
4.90 
4.38 
4.04 
3.55 
4.41 
5.00 
4.11 
4.56 
4.06 
2.69 
3.26 
4.07 
3.63 
5.25 
4.08 
3.69 
3.83 
5.54 
3.87 
4.20 
5.40 
3.89 
3.74 
3.75 
6.75 
4. 50 
4.00 
5.04 
3.75 
4.29 
5.72 
3.83 
4.58 
5.53 
4.59 
3.42 
4.49 
3.96 
L 00 
3.34 
3.11 
2.50 
L 72 
3.55 
0.97 
4.49 
3.54 
5.86 
4.44 
3.19 
3.16 
L 91 
2.52 
L 67 
1.35 
3.06 
3.43 
4.72 
2.08 
4.32 
L 10 
L 90 
2.29 
2.88 
4.40 
3.01 
5.24 
1. 17 
2. 60 
4.44 
0.39 
-0 .41  
11.48 
1.98 
L 96 
0.44 
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through the points with a one sigma (C ) bandwidth. 
coefficient of approximately 0. 8 was obtained indicating that the line 
is a reasonable f i t  through these points. 
is seen to be approximately 1 ID50 /ml.  
concentrations of lo4 - 10’ l[D50/ml. 
apparently at the saturation level for this particular test. 
these conditions, it appears a s  i f  the maximum clumping occurs at a 
The correlation 
The sensitivity of the system 
The data seen in Figure 1 show little dose-response at  
These viral  concentrations a r e  
Under 
coxsackievirus concentration of 10 2 ID50/ml. A partial explanation f o r  
this saturation or concentration effect is the lack of enough specific 
i viral antibody on the surface of the particles to  show a dose-response 
at higher antigen concentrations. As a result, the virus particles 
that a r e  added at  high concentration quickly attach t o  the specific si tes 
on the beads, effectively saturating each bead combining site. This 
phenomenon acts to prevent the formation of bead/Ab/Ag/Ab/bead 
complexes. 
From these data presented here, it is reasonable to expect 
that the sensitivity and reliability of this system can be improved. In 
our opinion, sensitivity determinations run with a single standardized 
preparation would increase the sensitivity of the PIA system fo r  the 
coxsackievirus by a factor of 10. An additional ten-fold increase in 
sensitivity could be obtained with a sensitized bead preparation made 
with higher t i ter  antibody. 
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3.1.1.1 PROPOGATION AND CHARACTERIZATION 
OF COXSACKIEVIRUS TYPE A2 
The Sickle and Daldroff isolate of Coxsackievirus Type A2 
was received in our laboratory from NCDC a s  a 20% suspension of the 
7th passage in suckling albino mice. The seed had been assayed in 
suckling mice (lo7 ID 
was propagated from a 
each of the 
sufficient number of 2 to 4-day old suckling albino mice to yield a 
harvest of 200 ml of 2070 mouse brain suspension in agamma horse serum. 
/ml) on 7/21/67. Passage 1 in our laboratory 
Aliquots of 0 .01 ml 
50 
dilution of the seed. 
dilution were injected intracerebrally (IC) into a 
~ The mice became moribund in 36 to 48 hours and were sacrificed after 
3 complete paralysis. The brains were removed and homogenized in a 
The t issue debris was removed by centrifugation at Waring blender. 
approximately 10, 000 g for ten minutes. 
Assay of the 207’0 mouse brain suspension was carried out 
in 2 t o  4-day old suckling albino mice. 
prepared in Hanks’ Balanced Salt Solution (HBSS). Litters of not l e s s  
than 5 mice each were innoculated IC in duplicate for each dilution with 
0.01 ml of the proper dilution per mouse. 
daily for paralysis and ultimately death. 
24 hours postinoculation were considered a s  due to traumatic o r  nonspecific 
events. 
in 36 to 40 hours and dead in 48 to 64 hours postinoculation. 
of deaths in each dilution was recorded over a period of ten days. 
t i ter  was calculated by the Reed-Muench method a s  4 x 10 
Serial 10-fold dilutions were 
The mice were observed twice 
Any deaths occurring in the f i r s t  
Mice innoculated with infectious coxsackievirus were moribund 
The number 
The 
6 ID50/ml. 
1366 
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3.1.2 ECHOVIRUS, TYPE 9 
The echovirus used in this study was propagated on African 
Green Monkey Kidney (AGMK) cells, and the antiserum used to sensitize 
the latex particles was obtained from (NASA (1:128 CF ti ter) .  
The detection sensitivity of the PIA system f o r  the echovirus 
was evaluated in two parts, the first consisting of 26 tests and the second 
consisting of 31 tests. 
mine some of the non-biological factors affecting the background level 
and the sensitivity of the reaction. 
different not only because of the different sources of antibody for the dif- 
ferent agents, but also because of the uniqueness of each viral antigen mosaic. 
The reasons for this type of evaluation was to deter- 
Each antigen/antibody system is slightly 
,z In the first ser ies ,  26 tests were performed with the echovirus. 
Figure 2 is a summary graph representing the averages of the first se r ies  
tested. 
This figure shows dose-response function. 
f i t  is given in Figure 2 and has a correlation coefficient of 0.81. 
ciated with these curves is a 1 sigma bandwidth. 
that the upper band of the control and the lower band of the signal intersect 
at  an agent concentration of 3 PFU/ml. 
The experiments were conducted at  four viral  concentrations. 
The formula f o r  a best linear 
Asso- 
The data in Figure 2 show 
The next ser ies  consisted of 31 tests. Figure 3 shows the 
signal curve and background curve, and the formula for  a best-fit straight 
line through the signal curve for  the second test  series. 
coefficient of 0.88 represents a good fit through these points and shows an 
increased reliability over the first test  series. 
is a 1 sigma band around both the signal and control curves. In Figure 3 ,  
the upper band of the control curve and the lower band of the signal curve 
intersect on the abscissa at  1 PFU/ml. 
intersection obtained in Figure 2. 
The correlation 
Associated with these curves 
This compares to  the 3 PFU/ml 
The curves in Figures 2 and 3 show some of the factors that a r e  ) 
involved in sensitivity determinations that a r e  not associated with the 
mechanics of the test  itself. The increase in sensitivity obtained was due 
in large part to the decrease in fluctuation that occurred in the signal and 
control curves, probably because of the learning associated with repeated 
testing. This decrease in fluctuation was measured by the standard 
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deviation associated with the average of the control points. 
ser ies  of experiments, the absolute average control value was slightly 
reduced, but the fluctuation in the control values was reduced by approxi- 
mately 33 percent. It was this reduction in fluctuation that accounted for 
the slightly increased sensitivity. 
In the second 
Tables 3 and 4 show the average results of the same two ser ies  
Tables 5 and 6 show results of the individual experiments that of tests. 
were performed. 
the signal is lower than at  lower agent concentrations. This concentration 
effect has been noticed in other virus/antibody systems in our laboratory. 
Work with the mycoplasma has shown that increasing the t i ter  of the antibody 
3 In each case at  a virus concentration of 10 P F U / r n l ,  
'1 globulin can increase both the sensitivity and the concentration or  dynamic 
The PIA test  has been shown to detect the echo- range of the PIA system. 
virus successfully, and it is felt that the concentration effect that is now 
observed at  l o 3  PFU/ml can be alleviated with higher titered antibody. 
Likewise, the sensitivity of the system would be improved. 
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Table 3 
Average S -N of PIA Determinat ions w i t h  the Echovirus  as Measured  
by Mean Clump Size 
{ 1st Series) 
Echovirus  
C once nt r a t ion, 
PFU/ml* Signal (S) Noise (N) S-N 
lo3  4.26 4.02 0 .24  
lo2  
loo 
10-1 
i 
10 
5 .24  
5. 56 
4. 84 
4.55 
Average Noise = 4. 15 
Standard Deviation = 0 . 6  1 
* 
Plaque - forming  units 
3. 52 1. 72 
4 .24  1. 32 
4. 52 0. 32 
4 .33  0 .22  
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Table 4 
Average S -N of PLA Determinations w i t h  the Echovi rus  as Measured  
by Mean Clump Size  
(2nd Series) 
Echovi rus  
Concentration, 
P F U / m l *  Signal (S) Noise (N) S -N 
l o 3  3.58 4 .11  -0.53 
l o 2  5. 80 3. 84 1. 96 
10 5 .83  3.99 1. 84 
i 
loo 5.40 3. 66 1. 74 
10-1 4 .21  4. 52 -0. 31 
Average Noise = 3.96 
Standard Deviation = 0.45  
* 
Plaque - forming units 
? 
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Table 5 
PIA SENSITIVITY DETERMINATIONS WITH THE 
ECHOVIRUS AS DETERMINED BY MEAN CLUMP SIZE 
(1st Series) 
Echovirus Signal Noise 
C once nt ration Mean Clump Size Mean Clump Size 
P F U / m l *  (S ) (N) S -N 
10; 
1°2 10 
100, 
3 
loo 
loo  
loo 
4.98 
4. 38 
4. 83 
2.82 
4. 16 
5. 05 
3. 63 
4.21 0.77 
3.51 0.87 
4.06 0.77 
3. 89 -1.07 
4. 36 -0.20 
3.69 1. 36 
4.40 -0.77 
4. 18 3.39 0.79 
5.42 3.20 2.22 
6. 13 3.97 2. 16 
5. 65 
4. 86 
4.94 
6. 04 
6. 80 
4.42 
6.02 
5.73 
3. 59 
5.58 
4. 72 
5. 70 
4.91 
4. 88 
4. 36 
4.92 
5.00 
3.74 
3.48 
5.53 
3.55 
3. 32 
1. 29 
-0.06 
-0.06 
2. 30 
3. 32 
-1.11 
2.47 
2.41 
3.93 -0.34 
4. 65 , o .  93 
4.43 0. 29 
4. 71 0.99 
5. 14 -0.23 
4.47 0.41 
10-1 4.55 4.33 0.22 
* 
Plaque Forming Units 
1366 Page 17 
TABLE 6 
PIA SENSITIVITY DETERMINATIONS WITH THE 
ECHOVIRUS AS DETERMINED B Y  MEAN CLUMP SIZE 
(2nd Series) 
Echovirus Signal Noise 
Concentration Mean Clump Size Mean Clump Size 
PFU/ml (S 1 ( N) S-N 
3.77 3.63 0. 14 
3.40 4.60 -1.20 
5.89 4.12 1.77 
6.50 3.72 2.78 
5.00 3.77 1.23 
5.80 3.50 2.30 
6.22 4.00 2.22 
5.81 3.52 2.29 
5.42 4.23 1. 19 
6.02 4.42 1.60 
6.07 3.67 2.40 
7.40 3.80 3.60 
5. 19 3.70 1.49 
5.58 4. 17 1.41 
5.71 3.99 1.72 
5.06 3.76 1.30 
5.63 4.45 1. 18 
5.35 3.70 1. 65 
6.79 3.96 2 . 8 3  
5.10 3.85 1.25 
2.60 6.00 3.40 
5.20 2.93 2.27 
4.97 3.77 1; 20 
5.08 3.37 1.71 
4.74 4.31 0.43 
3.96 4.17 -0.21 
10- 4.30 4.80 -0.50 
0 
lo 0 
lo 0 
lo 0 
lo 0 
10-1 4.39 4.61 -0.22 
;-1 
::Plaque Forming Uni t s  
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3.1.2.1 THE PROPAGATION AND CHARACTERIZATION 
OF ECHOVIRUS TYPE 9 
Echovirus Type 9 seed was received in our laboratory as 
7 14MK, dated 6/7/68. The t i ter  was listed a s  10 infectious unitslml. 
Passage 1 pools were prepared on monolayers of WI-38 cells and AGMK 
cells in 32 oz prescription bottles. 
in Hanks' BSS to infect 10 bottles of each cell type with 1 ml each. 
bottles were incubated one hour and each was fed 50 ml of HBME with 10% 
fetal bovein serum. 
at  37OC when approximately 90% of each monolayer was destroyed. 
A lo-' dilution of seed was prepared 
The 
The virus was harvested af ter  72 hours incubatim 
were conducted in 
1 AGMK 
and P 
homologous cell lines. The plaque technique was used for both assays. 
Monolayers of WI-38 and AGMK cells were prepared in 25 cm2 Falcon 
plastic flasks. 
0.1 ml per flask was innoculated in triplicate into the cell line in which 
the virus was grown. 
overlaid with Basal Medium Eagle's with Hanks' Salts (HBME) containing 
1% agar and 270 fetal bovine serum. The flasks were incubated a total of 
11 days and refed at the midpoint with more of the agar-medium mixture. 
1 WI-38 The assay of P 
Ten-fold ser ia l  dilutions were prepared from each passage 
The flasks were incubated one hour a t  37OC and then 
The cells were stained with neutral red containing medium and plaques 
scored after an additional 24 hours of incubation. 
3 . 5  x 10 PFU/ml for  P WI-38 and 3.8 x 10 PFU/ml for  P 
1 
Titers were found to be 
5 7 
1 AGMK. 
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3.1.3 HERPESVIRUS HOMINIS 
PIA sensitivity determinations were performed on concentrations 
of herpesvirus ranging from lo4 - lo1 PFU/ml. 
selected for these experiments was identical with the previously mentioned 
systems. 
and Table 7. 
rounded by their respective 1 sigma bandwidths. 
of 0.99 shows an excellent dose-response in the concentration range of 10'- 
10" PFU/ml. The intersection of the lower band of the signal curve and 
upper band of the control curve occurs a t  0.6 PFU/ml, a measure of the 
sensitivity of the system. 
The incubation time 
The results of these experiments a r e  summarized in Figure 4 
Figure 4 shows the average signal and control curves sur-  
The correlation coefficient 
Table 7 again shows the possible effects of a prozone-like phenomenon >) 
or saturation effect at high agent concentrations that was previously discussed. 
Table 8 shows the results of the individual experiments used in the PIA sensi- 
tivity measurements of the herpesvirus. 
with a standard deviation of 0.37, reflect a good reproducibility in the 
herpesvirus system. 
The average control value of 4.0 
3.1.3.1 THE PROPAGATION AND CHARACTERIZATION 
OF HERPESVIRUS HOMINIS 
A CAM pool of herpesvirus was produced by infecting the 
CAM of 12-day old embryonated hen's eggs with 0.1 ml of a lom2  dilution 
of the herpesvirus seed. The eggs were incubated for 48 hours at 35OC. 
The virus was harvested by removing the membranes and grinding them 
in a tissue grinder to a 20% (V/V) suspension. The debris was removed 
by sedimentation at 5, 000 rpm in a refrigerated SS34 Serval1 centrifuge 
for 10 minutes. 
Pools of herpesvirus were prepared in CEF and AGMK cells 
i 
/ by infecting three 32 oz bottles of each cell type with 0.1 ml  of the herpes- 
virus seed. 
were fed with 50 ml each of Basa Eagles medium in Hanks' balanced salt 
The bottles were incubated for one hour at 37OC; the cells 
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Table 7 
AVERAGE OF VARYING CONCENTRATION OF THE HERPESVIRUS 
AS MEASURED B Y  MEAN CLUMP SIZE 
Herpesvirus 
C once nt ration 
PFU/ml* Signal (S) Noise (N) S-N 
lo4 4.90 3. 83 1. 07 
lo2  6.06 4.20 1. 86 
,I 10 
loo 
10-1 
10 -2 
5.63 
4. 80 
4.48 
3.62 
Average Noise = 4 .0  
Standard Deviation = 0. 37 
* P F U  - Pock Forming Units/ml 
4. 06 
3. 90 
4. 23 
4.10 
1.57 
0.90 
0.25 
-0.48 
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TABLE 8 
PIA SENSITIVITY MEASUREMENTS O F  THE HERPESVIRUS AS 
DETERMINED BY MEAN CLUMP SIZE 
Herpesvirus Signal Noise 
Concentration Mean Clump Size Mean Clump Size 
PoFU/ m1:X (S 1 (N) S-mr. 
*Pock Forming Units 
4.80 
5.03 
4.87 
5.21 
5. 14 
7.79 
6. 17 
5.99 
4.82 
4.81 
6.20 
6.47 
5.86 
5.04 
4.44 
5. 17 
4.58 
4.81 
4. 15 
4.49 
3.62 
3.91 
3.99 
3.59 
3.87 
4.19 
4.48 
4.28 
4.16 
4.69 
3.88 
4.08 
4.03 
3.62 
3.76 
3.62 
3.99 
4.22 
4.23 
4.44 
4.01 
4. 15 
0.89 
L 04 
1.28 
L 34 
0.95 
3.31 
L 89 
1.83 
0. 13 
0.93 
2.12 
2.44 
2. 24 
1.28 
0.82 
1. 18 
0.36 
0.58 
-0.29 
0.48 
-0.53 
/ I 
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solution (HBME). 
and observed after 24 hours for  cytopathic effect (CPE). 
most of the monolayers were destroyed or showed gross CPE. 
from these cytopathized cultures was harvested and assayed separately 
on homologus cell monolayers. 
The infected cells were incubated 48 hours a t  37OC 
After 48 hours 
The fluid 
The herpesvirus harvests were assayed by the plaque technique 
of Dulbecco and by the pock method of Burnet and coworkers where 
applicable. 
The herpesvirus grown on the CAM was made into a 2070 
suspension a s  already described. 
of the suspension was used to make 10-fold ser ia l  dilutions. 
dilution a 0.05 ml  aliquot each was innoculated onto the CAM of six 12- 
day old embryonated hen's eggs. 
were floated in saline and the pocks were counted and end-points determined 
following Armitage's method of analysis. 
ml  were then calculated. 
pock technique with a resultant t i ter  of 2 . 5  x CAM lo6  PoFU/ml. 
The harvests f rom CEF P1 and P 2  and AGMK P1 were 
It was assayed on CAM. An aliquot 
From each i 
After incubation at 37OC, the membranes 
Pock forming units (PoFU) per 
Herpesvirus Pi was assayed on CAM by the 
assayed f ro  plaque forming units ( P F U ) .  
plastic Falcon plastic tissue culture flasks were used. 
dilutions were prepared from the tissue culture harvest. 
innoculated in triplicate with 0.1 ml  each per dilution. 
incubated for 1 hour at  37OC, then overlaid with HBME containing 1% 
agar. 
overlay of HBME with 1% agar containing neutral red 1:40,000, final 
concentration. After 24 hours of staining, the plaques were scored 
and t i ters  calculated. 
Monolayers of CEF in 250 ml  
Ten-fold ser ia l  
Flasks were 
The flasks were 
The flasks were then incubated for  48 hours and stained with an 
,) Plaques stand out on a neutral red stained monolayer back- 
ground a s  clear unstained circular areas.  
portional to  the amount of live virus present in the inoculum since the 
agar overlay restr ic ts  the spread of the virus. 
6 pi and P2 CEF were found to  contain 4.6 x 10 and 4.7 x lo6 PFU/ml 
respectively. 
The number is directly pro- 
Using this technique 
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3.1.4 ADENOVIRUS, TYPE 4 
PLA sensitivity determinations were performed on the adeno- 
4 
virus under experimental conditions identical with the herpesvirus exper - 
iments. 
l o m 3  TCID50/ml with a useful detection range of lo4 - 10-1 TCID50/ml. 
Figure 5 shows the average signal plotted against agent concentration. 
was linear only for concentrations of 10” to lom1. 
dynamic range plus a sensitivity of 3-5 TCID 
utable to  the low complement fixation t i ter  (1:40) of the antibody received 
from NASA. 
large concentration effect which can be seen from Table 9, together with 
a low average control of 2 .7  and standard deviation of 0.33. This effect, 
which is a result of either antigen excess or  scarcity of antibody, is shown 
1 by the lack of a dose response at adenovirus concentrations higher than 10 
TCID50/ml. 
Table 10. 
The concentrations of the adenovirus tested ranged from 10 to 
This figure shows that the dose response of the adenovirus 
This very narrow 
/ m l  can be directly attrib- 50 
The low-titered antibody also accounts for  the prominent 
The individual experiments that were performed a r e  shown in 
An increase in antibody ti ter  would not only extend the dynamic 
range of the PIA test  for adenovirus but also increase the sensitivity by at  
least one order of magnitude. 
I 
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Table 9 
AVERAGE PIA SENSITIVITY DETERMINATIONS WITH THE 
ADENOVIRUS AS DETERMINED BY MEAN CLUMP SIZE 
Adenovirus 
C one e ntr ation 
TC ID,, / ml* Signal (S) Noise (N) S -N 
lo7  3.42 2. 76 0.66 
lo5 3.12 2.92 0.20 
l o 3  
lo2 
‘1 2.89 2.61 0.28 
2.92 2.76 0. 16 
10 3.03 2.65 0.38 
loo 2.88 2.86 0.02 
10-1 2. 76 2.61 0.15 
Average Noise = 2.72 
Standard Deviation = 0. 3 3  
* 
TCID - Tissue Culture Infectious Dose 
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TABLE 10 
PIA SENSITIVITY DETERMINATIONS WITH 
ADENOVIRUS AS MEASURED B Y  MEAN CLUMP SIZE 
Adenovirus Signal  Noise 
Concentrat ion Mean Clump Size  Mean Clump Size  
10; 3.42 2.76 0 . 6 6  
3.47 3.02 0 . 4 5  
-2.76 2.82 0 . 0 6  
3.30 2 .81  0 . 4 9  
2.60 2.57 0 . 0 3  
2.77 2.38 0 . 3 9  
-2 .91  2.68 0 . 2 3  
2.96 2.92 0 . 0 4  
2. 63 2.67 -0 .04  
2.37 2 .25  0 . 1 2  
2.94 3.00 -0 .06  E; 3.09 2.85 0 . 2 4  
3.53 2.90 0 . 6 3  
3.05 3.45 -0 .40  
2.25 2.23 0 .02  
2 .64  2.55 0 . 0 9  
2.92 2.33 0 . 5 9  
3. 17 2.49 0. 68 
2 .61  2 .40  0 . 2 1  
3.67 2 .71  0 . 9 6  
3 .96  3.05 0 . 9 1  
2.03 2 .06  - 0 . 0 3  
2.67 2.90 -0.23 
2.63 2.77 -0.14 
2.68 2 .74  -0 .06  
2.35 2.69 -0 .34  
3 . 5 1  3.30 0 . 2 1  
3.66 3 .06  0 .60  
3.57 3 .36  0 . 2 1  
lo -1 2.83 2 .58  0 . 2 5  
10 2.36 2.40 -0.04 
10:; 2.8 1 2.62 0 .  19 
2.68 2.90 -0.22 
2,35 Z. 08 0.27 
3-25 2,64 0 . 6 1  
TCID50/ml t (S 1 ( N) S-N 
5 
*3 
lo 3 
1°3 
lo 3 
1°2 
1°2 
1°2 lo  
1 
1 
lo 1 
lo 1 
lo 1 
*1 
lo 1 
lo 1 
lo 0 
lo 0 
lo 0 
0 
0 
0 
0 
3.02 3.06 -0 ,04  
3 
10:; 
) lo-1 
” g-1 
’:Tissue Cu l tu re  Infectious Dose 
I366 Page 28 
3.1.4.1 THE PROPAGATION AND CHARACTERIZATION 
OF ADENOVIRUS TYPE 4 
Strain R1-67 seed adenovirus type 4 was received in our 
laboratory in the frozen state with the passage history of H19-8. 
Adenovirus was propagated on monolayers of H-Ep-2, 
HeLa and AGMK. 
was innoculated into three 32 oz prescription bottle monolayers of 
H-Ep-2, HeLa and AGMK cells. The bottles were incubated 1 hour at  
37OG, and then few with HBME (50 ml each) containing 10% (VLV) fetal 
bovine serum. 
The virus suspension was harvested and assayed by determining the 
) highest dilution of the harvest fluids which produced degeneration in 
One ml of a los2 dilution aliquot of the seed virus 
The infected cells were incubated at 37OC for 48 hours. 
50% of the cell cultures infected, the 5070 tissue culture infective dose 
(TCID50). 
Four 13 x 125 mm screw cap tubes of AGMK monolayers were infected 
per dilution fo r  each harvest. Each tube received a 0.05 ml  aliquot of 
the proper virus suspension. 
were fed with 2. 5 ml of HBME (containing 10% serum) and incubated for 
48 hours and scored for CPE. The titers were calculated by the Reed- 
Muench method. 
1.4 x l o6  TCID50/ml 
Each harvest was diluted in ser ia l  10-fold dilution with HBSS. 
After incubation for one hour, all tubes 
The results a r e  a s  follows: 
P1H e La 
Pi H-Ep-2 1. o x 105 T C I D ~ ~ / ~ ~  
pi AGMK 1.5 x 10 TCID50/m1 8 
i 
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3.1.5 MYXOVIRUS A2 INFLUENZA (HONG KONG) VIRUS 
PIA sensitivity determinations were performed with the myxovirus 
and with beads sensitized with anti-myxovirus antibody that was made in our 
laboratories (CF ti ter of 1: lOOO).  
Reaction conditions for  the tes t  were identical to those of the other 
tests. 
a 1 sigma bandwidth around the control and signal values. 
the sensitivity of th system to be approximately 10-1 EID 50/ml. The cor- 
relation coefficient for the linear best f i t  through the signal points is 0.87 
which shows a good dose-response. 
Figure 6 shows the signal plotted against agent concentrations with 
This figure shows 
The sensitivity of the PIA test  for the myxovirus can be determined 1 
from the intersection of the lower 1 sigma band of the signal and the upper 
1 sigma band of the control curve. 
is  approximately 0.1 EID50/ml. 
i. e . ,  1-10 EID5o/mle 
the test  for clinical sample testing. 
The sensitivity under these conditions 
This sensitivity is well below that required; 
The next step would be to  increase the reliability of 
2 Table 11 shows that at  virus concentrations higher than 10 a 
prozone effect was evident, a s  demonstrated by a lower signal a t  higher 
virus concentrations. This concentration effect was also evidenced with 
the other virus systems. This effect for the myxovirus should not cause 
serious problems in diagnostic work for it is highly unlikely that a 10 
EID5o/ml mkxovirus concentration would exist in a clinical sample. 
12 shows the results of the individual experiments that were performed 
with the myxovirus, with an average control value of 3.05 and standard 
deviation of 0.38 which is within expected limits. 
2 
Table 
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Table  11 
AVERAGE SIGNAL OF VARYING CONCENTRATIONS OF THE 
MYXOVIRUS AS DETERMINED BY MEAN CLUMP SIZE 
Myxovirus 
C oncentr  at ion 
EID50/ml* Signal  (S) Noise (N) S-N 
lo3  
lo2  
loo  
) l o 1  
10- 
4.05 2.71 1.34 
4.20 2.98  1.22 
3. 52 2.54 0 .98  
3.77 3. 19 0.58 
3.55 3.02 0 .53  
3. 32 3.33 -0 .01  
Average Noise = 3.05 
Standard  Deviation = 0. 38 
EID - Egg Infectious Dose 
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TABLE 12 
PIA SENSITIVITY DETERMINATIONS WITH MYXOVIRUS 
AS DETERMINED BY MEAN CLUMP SIZE 
M yx ovi r us Signal Noise 
Concentration Mean Clump Size  Mean Clump S ize  
EID50/ml  96 (S) ( N) S - N  
2 
loo 
lo 0 
lo 0 
lo 0 
lo 0 
lo 0 
10- 1 
10- 1 
lo 0 
0 
-1 
-1 
10 
10- 
10 - 
::Egg 
I3 66 
3.52 
3.33 
3.07 
3.77 
3.97 
2.86 
3.85 
3.39 
3.42 
3.40 
3 .60  
4. 16 
4.77 
3.33 
4.81 
4.32 
4. 14 
3.56 
4.63 
3.75 
3.47 
3.08 
3.92 
3.72 
4.24 
3.30 
2.95 
3.50 
3.97 
3.70 
3.95 
3.64 
4.49 
3.65 
3 . 1 1  
3.47 
3.79 
4 .01  
3.96 
3.67 
4.27 
3.88 
3 .51  
3 .94  
3.29 
3*49  
3.37 
2.50 
3 .21  
2.98 
3.09 
2 .81  
2.95 
3.06 
2 .84  
2.79 
2.75 
2.58 
3.13 
3 .06  
2 .61  
2.81 
2.86 
3. 14 
2.85 
3 .30  
2.90 
2.86 
2 .34  
2.77 
2.58 
2.60 
2 .81  
2 . 4 5  
2.24 
3.10 
3 .44  
3.23 
3 .01  
3.05 
2.92 
2 .91  
2.94 
2 .95  
3.64 
3.43 
3 .65  
3.18 
2.73 
3.25 
3.08 
2.97 
3.28 
3.39 
2.93 
2.38 
0 . 3 1  
0.35 
-0.02 
0.96 
L 02 
-0.20 
L 0 1  
0.60 
0.67 
0.82 
0.47 
L 10 
2. 16 
0.52 
1.95 
1. 18 
1.29 
0.26 
L 73 
0. 89 
1. 13 
0 .31  
L 34 
1.12 
1. 43 
0.85 
0 .71  
0.40 
0.53 
0.47 
0.94 
0.59 
L 57 
0.74 
0. 17 
0.52 
0.15 
0.58 
0 .31  
0.49 
1.54 
0.63 
0.43 
0.97 
0.01 
0.10 
0 .44  
0.12 
Infectious Dose 
TABLE 12 (continued) 
PIA SENSITIVITY DETERMINATIONS WITH MYXOVIRUS 
AS DETERMINED BY MEAN CLUMP SIZE 
Myxovirus Signal Noise 
Concentration Mean Clump Size Mean Clump Size 
EID50/ml * (S 1 (N) S - N  
3.65 
3.11 
3.79 
3.49 
3.04 
3.28 
3.92 
2.58 
3.03 
3.10 
3.72 
3.20 
2.94 
3.80 
3.05 
3.50 
3.49 
3.78 
3.79 
2.73 
2.90 
3.73 
3.28 
3.76 
0.71 
-0.69 
0.74 
-0.01 
-0.45 
-0.50 
0. 13 
0. 13 
0.44 
-0.15 
-0.63 
-0.56 
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3.1.5.1 PROPAGATION AND CHARACTERIZATION 
OF THE MYXOVIRUS 
The Asian influenza virus (Hong Kong strain, egg passed only) 
The specimen was reconstituted was received in  the lyophilized state. 
and three aliquots of 0.1 ml each were innoculated into the chorioallantoic 
sac of three 10-day old embryonated hens' eggs, 0.1 ml  per egg. 
aliquot of 0.1 ml  was diluted by four 10-fold serial  dilutions with Hanks' 
Balanced Salt Solution (HBSS), pH 7.2. 
was innoculated into the chorioallantoic sac of 10-day embryonated hen's 
eggs in quadruple. 
An 
An 0.1 ml  aliquot of each dilution 
The chorioallantoic fluid from each egg was harvested 
) and stored separately after incubation at 35OC for 48 hours. 
vest was tested for hemagglutination (HA) by mixing an aliquot of each 
with an equal volume of 0. 5% chicken red blood cells (RBC). 
f rom dilutions and were positive for HA. A titration for HA 
activity demonstrated an end-point at 1:64 for harvests from the 10- 
dilution. A second passage, (P2), of the harvest diluted through 
l o m 4  again gave a peak HA ti ter at the dilution; this time the titer 
was found to be 1:128. 
1:256 but a fourth passage did not increase hemagglutinating activity. 
Each har-  
The harvests 
3 
The third passage increased the HA ti ter to 
The harvest from passage 4 was assayed for infectivity. 
10 6 . Further passages of the myxovirus did not affect the HA t i ters  
The 
titer, in  50% response egg infectious doses 
1 
but did elevate the EID50 to 1.6 x 10 . 
hemagglutination reaction. The egg harvest, allantoic fluid, was diluted 
in  doubling dilutions with 0.1 M phosphate buffered saline (PBS) in test 
tubes. 
was found to be 
8 
The first assay method used for the influenza virus was the 
Each dilution received an equal volume of 0. 570 checken RBC. 
) After mixing, the test  was allowed to incubate 1-1/2 h r s  at 22 C with 
Agglutination 
0 
observations for hemagglutination at 30 min intervals. 
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signifies presence of the virus and non-agglutination signifies absence 
of the virus, 
taken a s  the end-point. 
The tube with the highest dilution giving agglutination is 
A modified version of the HA test was also used to measure 
the amount of infectious virus present; i. e., the egg infectious dose 
(EID50) titration method. 
used to place the 50% response dilution. 
The standard Reed-Muench technique was 
The EID50 end-point assay of influenza virus was conducted 
by innoculating the chorioallantoic sac of 10-day old embryonated hen's 
eggs in quadruple with 0.1 ml  of l0Afold serial  dilutions of the virus 
) suspension in question. The eggs were incubated at 35OC for 48 hrs.  
The chorioallantoic fluid was harvested; the yield for each egg kept 
separately. 
volumes of the individual harvest fluids with an equal volume of 0.470 
human 1101' RBC. 
at room temperature. 
showing HA activity in 50% of the eggs infected. 
method was used to calculate the EID50. 
Tests for HA activity were conducted by mixing equal 
The end-point of HA activity was read after 1-1/2 h r s  
The end-point was taken at  the highest dilution 
The Reed-Muench 
Passage 3 was the f i rs t  pool size harvest of the influenza 
virus with a sufficiently high titer to provide meaningful information on 
aging. 
EID50 activity stored at  -65OC as the raw harvest fluid. 
Over a six-month period P3 showed essentially no loss of HA or 
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3.1.6 MYCOPLASMA PHEUMONIAE 
Initial sensitivity tests with Mycoplasma pneumoniae showed that 
the PIA detection sensitivity was approximately 10 
forming units). At this level the signal was still marginal. The marginal 
tests were run with beads sensitized with NASA-supplied antibody that had 
a CF (complement fixation) titer of 1:16. 
one explanation for the low sensitivity could be the low ti ter of the antibody 
used to sensitize the beads. 
immunization schedule with the mycoplasma antigen. 
The CF ti ter of the resulting immune serum was 1:lOOO. 
fractionated with 1 /2  saturated ammonium sulfate and then with 1/3 saturated 
ammonium sulfate. 
polystyrene latex beads. 
obtained with the newly sensitized beads. 
in which the sensitized bead stock was diluted 1:5 before it was reacted with 
the antigen. 
In an effort to improve the sensitivity, the bead stock was not diluted before 
it was reacted with the antigen. The results of these tests a r e  also shown 
m TbMe 13 &M. The average control values of 2.39 with a standard deviation 
of 0.36 demonstrate a reasonable fluctuation for the number of samples run. 
- lo4 CFU/ml (colony- 
It was believed at the time that 
Consequently, rabbits were placed on an 
(See Section 3.1.5). 
This serum was 
This fractionated serum was then used to sensitize 1.1 P 
i 
Sensitivities of the order of lo3 CFU/ml were 
Initial experiments were performed 
The results from these experiments a r e  shown in Figure 7. 
The stability of the bead/ antibody bond not only determines the 
Lmge&y of the sensitized bead but also the maximum sensitivity that can 
be obtained with this particular reagent. Fluorescein isothiocyanate-tagged 
(FITC) rabbit anti-Bovine serum albumin (BSA) was heat fixed on 1.1 micron 
polystyrene beads in  the usual manner. The amount of tagged antibody that 
dissociated from the beads during one hour incubation at 40° C was measured 
by removing the beads from the solution by centrifugation and measuring the 
fluorescence in an Aminco Bowman spectrometer. 
that was found in the supernatant was approximately 10pg/ml. 
is equivalent to  1013 antibody molecules/ml. 
will neutralize about 5 x 10l2 BSA molecules/ml. 
also equivalent to  105 CFU/ml. However, not all the protein that is removed 
from the bead is antibody, which accounts for the higher than expected sensi- 
tivities. The soluble antibody binds the antigen in solution forming soluble 
antigen-antibody complexes that a r e  never detected because the antibody is 
The amount of protein 
This amount 
This amount of antibody molecules 
This quantity of BSA is 
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Table 13 
AYERAGE S-N OF PIA DETERMINATIONS WITH THE MYCO- 
PLASMA As DETERMINED B Y  MEAN CLUMP SIZE 
Myc op la s ma 
Concentrat ion 
F F U I r n l *  Signal  (S) Noise (N) S-N 
I 
lo4 3.71  2 .91  0.80 
lo3 
lo2 
lo1 
3.09 2.49 0.60 
2.66 2.57 0.09 
2.40 2 . 6 4  -0.34 
Control Average * 2.39 
Standard Deviation = 0. 35 
J. ‘1’ 
C F U  = Colony Forming Unit 
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Table 14 
PIA SENSITIVITY DETERMINATIONS O F  THE MYCOPLASMA 
AS MEASURED BY TIHE MEAN CLUMP SIZE 
Mycoplasma 
C onc ent ra t ion  Mean Clump Size Bead Stock 
CFU/ml:g Signal ( S )  Noise (N) S -N Dilution 
10 2.23 
10 2.43 
10 2.42 
10 2.36 
105 3.00 
lo4 
lo3 
10 
lo2 
lo1 
10 O 
10 
10 
10 
3 .71  
2.69 
3 .50  
2.98 
2.32 
2.68 
2.23 
2.58 
2.45 
Control  Average = 2. 39 
Standard Deviation = 0.35 
rtr ?-
CFU = Colony Forming Unit  ' 
1.70 
2.02 
2.07 
2 .11  
2.24 
2 .91  
2.37 
2.62 
2.93 
2.55 
2.22 
2.57 
2.71 
2.57 
0.53 
0 .41  
0.35 
0.25 
0.76 
0.80. 
0 .32 
0 .88  
0.05 
-0.23 
0.46 
-0.34 
-0. 13 
-0.12 
1:5 
1:5 
1:5 
1:5 
l :o 
l:o 
l:o 
l :o 
l :o  
l :o 
l :o 
l:o 
l:o 
l:o 
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not attached to a bead. 
Therefore, the theoretical maximum mycoplasma sensitivity that one can 
achieve with a heat-fixed antibody by the present procedure appears to  be 
1000-500 CFU/ml. This is the limit that has presently been achieved. 
To achieve the maximum sensitivity of 1-2 CFU/ml, it would be 
necessary to prevent the slow dissociation of the antibody from the bead. 
There a r e  cases in the literature where antibody has been covalently bound 
to a solid substrate. Unfortunately most of the substrates that have been 
used have either been of amorphous character or much larger than the 1.1 
micron sphere presently in use. Cellulose polymers have been used with 
reasonable success to covalently bind proteins. Sephadex G-25 superfine 
particles were used to determine if a cellulose polymer could be used to 
solidly fasten antibody in our case. These particles were 10-40 microns 
in size. 
available so a PIA test  in its present form was impossible. 
it was possible t o  test  the binding capacity of activated superfine beads. 
1 
Unfortunately, beads of smaller size were not commercially 
Nevertheless, 
It became apparent after the initial runs that increased antibody 
ti ter  is only a partial solution to the problem of low PIA sensitivities related 
to  the sensitivity with mycoplasma antigen. 
important role in the overall sensitivity of th system. 
antigen and the second is the quality of the sensitized bead in te rms  of the 
stability of the bead/antibody bond. 
Two additional factors play an 
One is the size of the 
The size of the antigen for  the PIA can be at least a s  small as  a 
BSA (bovine serumalbumin) molecule of 66,000 MW. By empirical measure- 
ment at 280 millimicrons, each mycoplasma antigen is the equivalent of 10 ? 
BSA molecules (per CFU). 
This means that there a r e  at  least  lo7 antigenic molecules avail- 
able for attachment in one C F U  if the mycoplasma antigen can be broken to 
that size range before reaction with sensitized beads. Theoretically, one 
mycoplasma CFU could be amplified in te rms  of the PIA test  lo7 times. 
The theoretical amplification will probably never be realized. 
initial evidence shows that freezing and thawing a suspension two or  three 
times will increase the sensitivity by 5070~ 
breakage would yield sufficient antigenic particulate s without denaturation 
) 
However, 
The optimum method of mycoplasma 
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of the antigen itself. 
automated system. However, such techniques as sonication and chemical 
lysis a r e  methods that have been used for the di sruption of other micro- 
organisms, and should therefore be applicable to the mycoplasma problem 
a s  well. 
Freezing and thawing would be cumbersome in an 
EITC-labeled gamma globulin attached to the Sephadex beads 
in approximately the same quantity a s  obtained using the heat fixation 
procedure. However, upon washing, the amount of protein that was released 
into the supernatant was one tenth the amount that was released from the 
heat-fizd particles. This method shows great promise for permanently 
binding the antibody to the beads and will be tested thoroughly as soon as 
’ 1-5 micron beads become commercially available. This antibody binding 
“1 
technique promises to increase the sensitivity of the PIA test for myco- 
plasma by at least one order of magnitude, which combined with breakage 
of the mycoplasma itself, should give the necessary sensitivity of 1-10 
CFU/ml. 
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3.1.6.1 THE PROPAGATION AND CHARACTERIZATION 
OF MYCOPLASMA PNEUMONIAE 
A frozen isolate of Mycoplasma pneumoniae was received in 
our laboratory from NASA. 
consisting of Difco PPLO medium fortified with 20% agamma horse serum 
and 2. 570 yeast extract. 
medium was innoculated with 3 ml of the seed. 
The organism were grown in liquid cultures 
A l i ter  flask containing 500 ml of the fortified 
At time zero and each 24 
hours thereafter, aliquots of the culture were taken andplated on fortified 
Difco PPLO agar. The plates were incubated under aerobic conditions at  
37OC. 
microscope. 
Colonies were scored in 7-10 days with the aid of a dissecting 
A growth curve was plotted s o  that it would be possible to  ’ harved the organisms during their most active growth stage, which 
The growth peak typically is near the end of the logarithnic phase. 
occurred between 192 and 216 hours. 
at  168 hours. 
168 hours (See Figure 8). 
The end of the log phase occurred 
All  M. pneumoniae utilized in the study were harvested at  -
For  assay, ser ia l  10-fold dilutions in Difco PPLO broth were 
prepared from an aliquot of the culture. 
60 mm diameter, containing fortified Difco PPLO agar were innoculated 
in triplicate with 0.1 ml from each dilution. 
a t  37OC and scored in 7-10 days. The t i ter  was calculated from the 
colonies counted; i. e., colony forming units (CFU)  per ml. 
assayed at 9 X l o5  CFU/ml. 
concentrated 50-fold by centrifugation at  16, 000 g for 60 min. 
drained pellet, except for a small aliquot in 10 ml of phenolized (0. 0570 
phenol) Verona1 buffer. The concentrate was titered at  10 CFU/ml 
when assayed on Difco PPLO agar. 
was produced and concentrated to 5 ml volume. 
Falcon plastic petri dishes, 
The plates were incubated 
The pool 
The 500 ml pool of M. - pneumoniae was 
The 
8 
A total of 2.5 l i ters  of M. - pneumoniae 
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l o5  
J /ml  
l o L  
10 
0 
Incubation time in hours 
Figure 8 
0 
Growth Curve of Mycoplasma pneumoniae grown a t  35 C in 
broth media. * notes time of harvest for use  as antigen (168 hrs.  ). 
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3 . 2  SPECIFICITY OF THE PIA TEST 
The usefulness of a specific detection system is only as good 
If the system is highly specific, identifications can a s  its specificity. 
be performed with a high degree of accuracy. 
type can also be made more general by either mixing sensitized beads of 
different specificities together or  changing the specificity of the antibody 
globulin before the beads a r e  sensitized. 
A specific system of this 
Table 16 shows the average S-N values of three heterologous 
agents reacted with each of the s ix  different sensitized bead preparations. 
In this table anything over to. 3 is considered a positive response, This 
’) table shows that there was negligible c ross  reactivity among the antigens 
tested. 
ments due to different antibody sources and different suspending fluids 
for  the antigens. Nevertheless, the results demonstrate that the speci- 
ficity of the PIA system for the agents tested is within acceptable limits. 
There was some scatter in the results of the individual experi- 
3 . 3  ANALYSIS OF CLINICAL SPECIMENS 
The feasibility of the PIA system was examined with regard 
t o  its effectiveness in detecting virus in clinical specimens. 
tage of testing clinical specimens with the PIA system is that the response 
time of 1-2 hours for the PLA test  is far shorter than that required for 
more conventional methods (1-14 days). This rapid response time and 
high sensitivity allows direct  examination of the specimen without growth 
amplification. 
The advan- 
Eleven clinical specimens were examined both with conventional 
techniques and with the PIA technique. 
were obtained from the Communicable Disease Center (CDC) in Atlanta, 
” Georgia through NASA, and five came directly from NASA. The clinical 
samples from CDC were throat swabs that had been placed in tryptose 
phosphate broth. The other samples were in HaQks’ BSS, physiological 
saline, or allantoic fluid. The conventional method for handling the 
clinical specimen is shown graphically in Figure 9 and explained in 
Section 3 . 3 .  
with the usual procedure performed in the laboratory. 
Six throat swab specimens 
The PIA procedure for handling the specimens was identical 
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(Negative for 
purpose of study) 
T f  T A W  
CLINICAL SAMPLE TREATMENT PROCEDURE 
F i g u r e  9 
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The specimens from CDC were approximately one year old. 
There was some difficulty in handling these specimens in the PIA test. 
There were two reasons for this difficulty. One reason was the age of 
the specimen 6-1 year), and the second reason was the tryptose broth 
suspending fluid of the sample. 
in tryptose broth because it is advisable to eliminate as much protein 
and protein by-products as possible from the reaction mixture. The 
excess protein material tends to interfere with the PIA reaction, and 
a s  a result 10-fold dilutions were made of the six samples for testing. 
The PIA test is not normally conducted 
The control fluid used for the clinical specimen examinations 
) was the suspending fluid of the sample being tested. The signal minus 
Par t  of the noise (S-N) from the four positive specimens was low. 
reason for this low signal was the 10-fold dilution at which the first six 
samples were run. 
available for detection. 
have already been discussed, i. e., the age of the sample and the suspend- 
ing fluids. 
pending medium such as tryptose phosphate broth. 
the sample will always be an important factor as numerous chemical and 
biological changes affecting antigenicity can occur even in biological 
samples that a r e  frozen. 
This dilution reduced the number of virus particles 
The other reasons for the low specific signals 
It is felt that the PIA test can be modified to utilize a sus- 
However, the age of 
The five clinical specimens obtained from NASA were fresh 
and were suspended in Hanks' BSS, physiological saline, o r  allantoic 
fluid. No unusual effects from these samples, such a s  those that had 
occurred with the first six, were noted. 
the clinical specimens a r e  shown in Table 16 
The results obtained with all 
The data in this table indicate that out of the first six speci- 
) mens received, three were positive, one weakly positive and two negative. 
Table17 shows the actual signals obtained 
Of the specimens received from NASA, 3 specimens gave a t4 reaction, 
one a t3 and one a t 2  reaction. 
from the samples. 
than did the last five. 
related to the date of dampling of the sample and the fact that samples 
7-11 were tested undiluted. 
tractual requirements and samples 10 and 11 were examined by oral  
request. 
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The first six samples shown gave much lower signals 
The reasons for the higher signals apparently 
Samples 1-9 were analyzed to fu l f i l l  con- 
Sample 9 gave the lowest signal of the 5 samples sent by NASA. 
Table  16 
PIA EXAMINATION O F  CLINICAL SAMPLES 
Date of 
Sample Source  Unknowns f o r  test Intensity Mean Clump Siz 
Dilution Re ac ti o n+ S ig na 1 - Noi s e 
1-3 - 69 CDC 1 G S P # 1  1: 10 
1-3 - 69 CDC 2 G S P # 2  1: 10 
1-2 1- 69 CDC 3 A-44 1: 10 
1-2 1- 69 CDC 4 A-51 1: 10 
3-12-69 CDC 5 A-68 1: 10 
3-17-69 CDC 6 A-62 1: 10 
4-2 0.26 
i-3 0.70 
t 4  0.80 
*l 0.09 
*l 0.05 
t 3  0.50 
2-70 NASA7 A 
2-70 NASA9 C 
2-70 NASA8 D 
2-70 NASA10 F 
2-70 NASA11 G 
undiluted t 4  0.93 
undiluted t 2  0.62 
undiluted t 4  L 15 
0. 82 undiluted t 3  
undiluted i4 1. 94 
:: Subjective evaluation of the agglutination r eac t ion  based  on a 0-4 
scale. 
difference f r o m  control). 
(0  indicates  no  agglutination, while t 4  indicates  a d r a m a t i c  
13 66 Pagc $9 
Table 17 
PIA DETERMINATIONS OF UNKNOWN CLINICAL SAMPLES 
Sample Signal Noise 
De  s ignator  (S) (N) S-N 
6SP#1 
6SP#2 
A-44 
A- 51 
A-68 
A-62 
! A  
C 
D 
F 
G 
2.76 
3.30 
3.25 
3.34 
3.54 
3.21 
3.36 
3.00 
3.77 
3.05 
4.22 
2.50 
2.60 
2.45 
3.25 
3*49 
2.71 
2.43 
2.38 
2.62 
2.23 
2.28 
0,26 
0. 70 
0.80 
0.09 
0.05 
0.50 
0.93 
0.62 
1.15 
0.82 
1.94 
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This low signal relative to those obtained f rom the res t  of the samples 
probably indicates cne of two things: (1) the virus was in lower concen- 
tration than other samples; or (2) the virus was not the exact one that was 
being sought but is closely-related antigenically. 
at present to be the best explanation. 
samples, and good HA titers could be obtained from the original samples, 
7-11, as well as from the allantoic fluid passage harvest. 
however, gave a low HAI compared to the HA titer. 
that the virus that was isolated is not the Hong Kong A2 variety but a 
closely-related virus such as Influenza B. 
tize the beads was prepared against Influenza Hong Kong A2 but was not 
absorbed with other antigenically similar viruses to remove cross  - 
reacting antibodies. For  increased specificity at the group level, cross  
reacting antibodies should be removed from the antisera. 
The latter reason appears 
Virus was isolated from all the 
Sample 9, 
This would incicate 
The antibody used to  sensi- 
'I 
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3. 3.1 
3.3.1.1 
CHARACTERIZATION OF 11 CLINICAL SPECIMENS 
ISOLATION OF INFLUENZA A2 HONG KONG VIRUS 
FROM MOCK CLINICAL SPECIMEN 
Preparatory work &or protocol testing was conducted on a 
mock clinical specimen which was divided into two aliquots. 
sample, was seeded with P3 influenza virus to give a final concentration 
of approximately 5 EID50/0. 1 ml. 
equal volume of steri le saline. 
and control were injected into the amnion of 11-day embryonated hens' 
eggs. 
fluids from each egg were separately harvested. 
were positive for HA in the amniotic and chorioallantoic fluids. 
control eggs were negative for HA in both the amniotic and allantoic fluids, 
The positive allantoic fluids were then typed with chick and human "0" 
RBCs. 
specimen could presumptuously be classified a s  Type A o r  B but not C 
influenza virus. The HA test was positive at both 4OG and 22OC within 
both cell types. The HA results were then confirmed by a standard HA1 
test  with antiserum prepared in our laboratories from P 
virus A2, Hong Kong. 
dilution of 1:2560. 
HA activity. The HA activity of the positive control virus, P was 
inhibited at 1:2560. 
One, the 
The other, the control, received an 
Aliquots of 0.1 ml from both the sample 
After 48 hours incubation at 35OC, the amniotic and chorioallantoic 
Half of the sample eggs I 
All the 
The results indicated that the isolates from the mock clinical 
of influenza 
3 
The serum was capable of inhibiting HA at a 
Control negative serum demonstrated no inhibition of 
3' 
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3. 3.1. NASA CLINICAL SPECIMENS 
Eleven clinical specimens were received in our laboratory, 
6 in the frozen state, and 5 in wet ice. 
the other five were received 2/17/70. 
follows : 
1/ 22/  70 2/17/70 
#1 GSP #1 1-3-69 # 7  A in Hanks' BSS 
#2 GSP #2 1-3-69 #8 C in allantoic fluid 
#3 VA A-44 1-21-69 #9 D in Hanks' BSS 
#4 VA A-51 1-21-69 #lo F in PBS 
A-68 3-12-69 # 11 G in PBS 
#5 
#6 
Six specimens arrived 1/22/70; 
The specimens were labeled as 
VA A-62 3-17-69 
One-tenth ml of each sample was tested for HA with 0.1 ml of 
0.470 human "0" RBC. 
0 . 3  ml each were then taken from each specimen and mixed with an 
equal volume of penicillin and streptomycin to give a final concentration 
of 400 units of penicillin and 400 ug of streptomycin/ml. 
embryonated hens' eggs were innoculated in the amnion with 0.1 ml of the 
treated specimen. After 48 hours of incubation, the amniotic and chorio- 
allantoic fluids of each egg were separately harvested. 
for  HA activity. The other 
harvests of each specimen were pooled, keeping the amniotic and chorio- 
allantoic fluids separate. 
injected into the amnion of 10-day embryonated eggs. 
each pooled specimen. 
specimen #2, #3 and #4 were positive for HA in both fluids. 
#6 were recycled after pooling each one in 10-day embryonated eggs. 
) second blind passage of specimen #5 and #6 was also negative for HA. 
All were negative for HA activity. Aliquots of 
Six 10-day 
Each fluid was tested 
Only specimen #1 was positive in the amnion. 
Aliquots of 0.1 ml of each pooled specimen were 
Ten eggs were used for 
Upon harvest of the individual fluids f rom this passage, 
Specimen # 5  and 
The 
Aliquots from the original # 5  and #6 samples were prepared and 
injected into the amniotic cavity of six 10-day embryonated eggs each. When 
harvested after 48 hours, both specimen were positive for HA activity in the 
amniotic and chorioallantoic fluids. 
1366 
The positive fluids were pooled for each specimen and aliquots 
of each were studied with the PIA technique. 
carr ied out on the isolates by conducting HA tests  at 4 and 22OC with 
human "0" and chick RBCs. 
A presumptive typing was 
The results were as follows: 
PRESUMPTIVE TYPING 
4OC 22% 
Spec. No. Chick Human Chick Human 
1 t t t t 
2 f t t t 
3 t t t t 
4 t t t t 
5 t t t t 
6 - t - t 
3 
From the above, it i s  presumed that a type A or type B 
myxovirus was isolated from each of the unknown specimen; specimen 
No. 6 could only be type A. 
studies on the isolates was employed for identification. 
Confirmatory typing followed by HA1 
Aliquots of each pooled specimen were taken for use in the 
study of HA activity. 
RBCs. 
The t i ters  were a s  follows using 0.47' human "0" 
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Specimen No. HA Titer (P2) 
1 1:4 
2 1:4 
3 1:16 
4 1:4 
5 1:160 
6 1:2 56:: 
‘Cipecimen was passed an additional time since its 
harvest t i ter  was less  than 1:20. 
These t i ters  were considered relatively too low to  complete the desired 
study. The t i ters  were increased by passing each isolate in the chorio- 
) allantoic sac of four 10-day embryonated eggs each. The HA t i ters  on 
p1 of each isolate were a s  follows. 
Specimen No. HA Titer 
1 1:128 
2 1:32 
3 1: 32 
4 1:64 
5 Not Done:: 
6 1~256 
*The t i ter  of Specimen #5 was sufficiently high without 
further pas sage. 
Using standard methods, four HA units of each isolate were 
prepared and used in an HA1 study. Each isolate was run in duplicate. 
The following results were obtained: 
HA1 STUDY 
Specimen No. HA1 Titer (confirmatory) 
1 1:12 80 
2 1:640 
3 1:12 80 
4 1:12 80 
5 1:12 80 
6 1:12 80 
Positive Control 
( P 3 )  
Negative Control 
(allantoic fluid) 
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The second ser ies  of 5 unknown specimen received from 
NASA (2-17-70) also included 3 control fluids. 
labeled: 
The specimen were 
7A in Hanks' BSS 
8C in allantoic fluid 
933 in Hanks' BSS 
10F in PBS 
11G in PBS 
12 B Hanks' BSS 
13E PBS 
14H Allantoic fluid 
The first three were necessary to complete the ser ies  of nine 
contractually required tests; the additional two were considered a s  ancil- 
lary, to  be processed if time permitted. The last three tubes were 
) control fluids. 
the controls, were injected into the amniotic cavity of six 10-day 
embryonated hens' eggs. 
egg were harvested, kept separate and spot checked for HA acti+ity. 
five unknowns were positive; the control fluids were negative. 
passes were made on the control fluids; they remained negative through 
a1 passed. 
isolate were used fo r  typing 
Aliquots of all the unknowns in the second series,  including 
The amniotic and chorioallantoic fluids of each 
The 
Two blind 
Amniotic and allantoic fluids pooled for each individual 
Presurnptive typing of the new isolates gave the following 
r e sult s : 
PRESUMPTIVE TYPING 
4OC 22OC 
Specimen Chick Human Chick Human 
7 + t t t 
8 t t t t 
9 t t t t 
10 t 4- t t 
11 t t t t 
These results indicate that all  the isolates could be either 
type A or  type B. Confirmatory tes ts  followed. 
The HA t i ter  was determined on the pooled individual 
amniotic and allantoic fluids from each new isolate. 
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Specimen HA Titer 
7 1:40 
8 1:160 
9 1~640 
10 1:160 
11 1:160 
Positive Control 
p 3  (CAI 1: 2 56 
Four HA units of each isolate were used in the HA1 test for 
confirmatory typing of each isolate. 
pool used with earlier isolates. 
1 in duplicate with the new isolates were: 
The serum used was from the same 
The results of the HAI tests conducted 
Specimen HAI Titers (confirmatory) 
7 1: 640 
8 1:40 
9 1:1280 
10 1:640 
11 1:2560 
p 3  (CAI 1:2560 
Positive Control 
Negative Control 0 
The unknowns, except #8, all appeared to  be type A influenza 
virus based upon the HA and HAI patterns. 
since its HA1 confirmatory t i ter  is so very low. 
of the unknowns were neutralized by 1:40 dilution of influenza A2 anti- 
serum in embryonated hens' eggs. 
Unknown 8 may be questionable 
50 
A 100 EID dose of all 
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3.4 PURIFICATION AND CONCENTRATION 
The purification and concentration of the crude virus suspensions 
were intended to  remove extraneous proteinaceous material and reduce 
the volume of the suspending medium. 
in this study, one general type of diaflo ultrafiltration membrane XM-100 
was used. This is the recommended membrane for purification and con- 
centration of viruses, globulins and macromolecules. The results of 
purification and concentration in Table 18 show that only two of the five 
organisms, echovirus type 9 and adenovirus, were purified and concen- 
trated to any extent with the XM-100 membranes. 
or better over that of the original; their pro- ti ein content decreased significantly from the originals. The other three 
viruses were not purified; indeed they concentrated protein with relative 
increase in infectivity. 
than two logs 
The Coxsackievirus effluent was very nearly the same a s  that of the 
original homogenate. 
cessing was higher than the starting material, while the protein content 
of the effluent was decreased. 
fluenza AZ did not change appreciably a s  a result of processing; the 
protein content of both suspensions was increased significantly. 
processed effluents of both suspensions had lower levels of protein than 
did the corresponding suspension. 
In processing the viruses used 
Their infectivity in- 
reased by almost a log 
(10) 
The infectivity of Coxsackievirus was more 
lower in the concentrate than in the starting material. 
The protein content of the suspension after pro- 
The infectivity of herpesvirus and in- 
The 
While these studies did not result in extremely pure or 
considerable concentration, they do indicate that purification and con- 
centration can be achieved with the technique. 
purification and concentration of the viruses used can be achieved by 
k ing  the proper size of filter membrane. 
The studies indicate that 
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3.5 STABILITY STUDIES 
The advantage of an inert car r ie r  versus a biological car r ie r ,  
such a s  a red blood cell, is the inherent stability of the former. 
"shelf life" of the sensitized bead then becomes a function of the longevity 
of the antibody and the carrier/antibody bond, and not of the ca r r i e r  system 
itself. Six batches of polystyrene beads each sensitized with antibodies 
to one of the six organisms under study were examined from the time of 
sensitization to the end of the present technical effort. Special consid- 
eration was given to the beads sensitized with myxovirus and mycoplasma 
antibodies which were tested at  one-month time intervals. The other four 
batches of beads were tested at greater intervals. 
stored at  4OC at a concentration of approximately 10 beadslml. These 
beads were tested at  intervals of approximately one month to  determine 
the effect of storage on the ability of the bead to retain its initial activity. 
Figure 10 shows the effect of storage on the sensitivity of the bead a s  a 
percentage of its original activity. 
and the adenovirus sensitized beads, no signiiicant difference in sensitivity 
were noticed after 7 months of storage. 
mycoplasma sensitivity is due in part  to the nature of the antigen itself. 
The antigen used for testing was stored for an approximately equal length 
of time. 
to more time-related change than the viral antigen. 
of the anti-adenovirus sensitized beads may be attributed t o  the poor 
quality of the original antisera. Based on sensitivity studies, some 
additional loss in sensitivity can be attributed to the slow loss of antibody 
from the bead which would tend to  form soluble antigedantibody complexes 
) in the reaction mixture. These complexes would not be detected. However, 
The 
1 
i 
The influenza and mycoplasma sensitized particles were 
9 
With the exception of the mycoplasma 
The reason for the decline in 
The mycoplasma antigen (due t o  its greater mass)  is subject 
The poor stability 
additional testing of the sensitized bead, increased quality control in the 
preparation, plus a more rigorous attachment (through higher -temperature 
binding) of the antibody to the bead should increase the effective stability of 
the sensitized bead to at  least one year. 
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3.7 ANTIBODY PREPARATION AND CHARACTERIZATION 
The antibody preparations received f rom NASA were charac- 
terized by the HA1 or  CF test. 
agent were obtained from Microbiological Associates. 
mercial  antigens and antisera together with those supplied by NASA has 
allowed precise reagent baseline titrations, providing a reference point 
for each reagent with which future immunological reactions could be 
compared. 
The data shown a r e  averages of at  least  three tests. The titrations that 
were performed included hemagglutination (HA), hemagglutination inhi -  
j bition (HAT.) and complement fixation (CF) (See Appendix A for  procedure). 
Diagnostic antisera specific for each test  
Use of these com- 
I 
Table 19 shows results obtained when the diagnostic antigens for  the 
myxovirus, adenovirus, herpesvirus and Mycoplasma pneurnoniae were 
reacted with both the commercial antisera and with NASA-supplied anti- 
sera.  
antigen propagated in our laboratory from the NASA seed were reacted 
with the diagnostic antiserum, NASA antiserum, and a gamma globulin 
fraction of the GFE antiserum (see Appendix A f o r  the fractionating 
procedure). 
both the diagnostic antigen and that propagated in our laboratory. 
(56OCfor 30 minutes), the C F  t i ters  were substantially reduced a s  
expected. 
course, indicate that the antibody activity has been lost. Indeed, the 
heat treatment i s  shown to have no effect on the PIA reaction. 
In the case of the myxovirus, both the commercial antigen and 
The commercial antiserum was also cross-ti tered against 
Table 19 also shows that when the se ra  were heat inactivated 
The observed decrease in CF titer upon heating does not, of 
The antisera to the six organisms under study were frac- 
tionated by a conventional ammonium sulfate precipitation technique 
) (see Appendix A for procedure). Before salt fractionation, each serum 
was treated with equal volurne of Freon 113 to remove many of the lipids 
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present in "raw" serum. 
previous studies have shown that the two-step technique provides an 
optimum sensitized latex preparation. 
used to sensitize polystyrene latex beads by a heat fixation reaction. 
Immunological schedules for Mycoplasma pneumoniae and 
A two-step fractionation is performed since 
The fractionzted sera  have been 
influenza A2 Hong Kong were set  up to produce higher-titered, specific 
antisera for the PIA laboratory experimentation. 
Injections were given to test  rabbits on a weekly basis with a 
gradual buildup in agent concentration. 
tions were dependent upon the reaction of the tes t  animal to the antigen. 
At  the end of seven weeks (seven injections), the rabbits were trial-bled 
) and the raw serum was  titered by a microtiter complement fixation (CF)  
The site and volume of the injec- 
method. 
The Mycoplasma schedule, due to good t i ters  and a time 
factor, was terminated after the seven-week period. The t i ters  ranged 
from 1:256 to11024 and were combined to form a pool having a t i ter  of 
1:512 (160 ml of fractionated antibody at a concentration of 7. 96 mg/ml). 
The myxovirus innoculated rabbits, a t  the end of seven weeks, 
produced C F  t i ters  averaging 1 : l O O .  
for  an additional three weeks using increased antigen concentrations 
and dual inoculation sites (I. M. and I. P. or I. M. and I. V. ) to boost the 
titers. 
The t i ters  ranged between 1:200 and L:400. 
tionated and stored for use. 
3. 7 
The schedule was then continued 
Sera f rom the test  animals were re-titered by complement fixation. 
The se ra  were combined, frac- 
PIA SENSITIVITY DETERMINATIONS WITH STREPTOCOCCUS 
The PIA test  has been demonstrated to be a highly sensitive and 
specific test  for viruses. 
any system involving an antigedantibody reaction, 
ment necessary to perform a successful PIA test, assuming the test 
reagents a r e  adequate, is that the antigen being detected be of relatively 
small size. 
sufficient to hold two sensitized beads together. 
a s  a bacterium, the probability i s  that it will still hold only two beads 
together. If the antigenic material on the bacterial cell is broken into 
smaller units, each antigenic unit i s  then capable of clumping tow 
particles. Therefore, each bacterium has the potential of holding large 
numbers of sensitized beads together, i f  the antigenic material can be 
removed from the cell proper. 
The capability of this test  can be extended to 
The only require- 
I 
The reason for this is that an antigen of 66, 000 MW is 
If the antigen is  as large 
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The feasibility of the PIA test  was examined for streptococcus 
5 detection, using 10 bacterialtest. The test was performed in an 
identical manner to the viral detection procedure. 
gave no detectable signal even at the 10 A solution 
of the streptococci at the identical concentration was processed through 
a French press  a single time. 
in complete chain breakage, and about 10% cell disruption a s  measured 
by cell counts. 
signals a t  10 bacteria/test level, 
The whole bacteria 
5 bacteria/test level. 
This single pass through the press  resulted 
PIA teste run on the partially broken cells gave significant 
4 These results were obtained in a 
single ser ies  of experiments and indicate that i f  the bacterial antigenic 
material is amplified (by either mechanical or chemical breakage ), higher 
)sensitivities a re  possible. Additional study is  clearly needed for the PIA 
test to be considered a s  a rapid, sensitive and specific method for 
detection of bacterial agents. 
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4.0 TECHNICAL DISCUSSION, THREE-MONTH CONTINUATION 
The technical effort, comprising the three -month continuation, 
encompassed the following major areas:  (1) improved antiserum production, 
(2)  optimization of process variables - to include the effect of varying in- 
cubation conditions, ionic strength of the suspending fluids, bead concentration, 
bead size and sample mixing, (3 )  specificity testing, (4) examination of 
readout techniques for the PIA test ,  and (5) clinical specimen testing. This 
work w a s  an  extension of the f i r s t  nine months' effort on the MEMS program 
and w a s  designed to obtain additional information regarding reliability and 
reagent quality for dependable operation of the PIA test. 
14.1 ANTISERUM PRODUCTION AND PURIFICATION 
Earl ier  PIA determinations with the Mycoplasma indicated that 
the sensitivity of the test was dependent (among several  other factors) on 
the quality of the antibody globulin attached to  the latex beads. 
attempts were initiated to prepare high-titered antisera to influenza A 
Kong virus and Mycoplasma pneumoniae. 
enough quantity of the antisera to complete the three-month testing program. 
The utilization of a standardized reagent would prevent inconsistencies 
associated with this particular biological parameter. 
Therefore, 
Hong 2 
It w a s  desired to produce a large 
The method for antigen preparation is described in Sections 4. 2. 1 
and 4. 2 .2 .  F o r  both agents, one goat and two rabbits were placed on the 
following immunization schedule. 
were administered to the animals. 
were taken (at weekly intervals) before each booster. 
antisera against each organism a r e  listed in Table 20  
Weekly shots of the appropriate antigen 
After the third week, trial bleedings 
The t i ters for the 
The t i ters  of the antisera w e r e  determined by using antigen 
;)sensitized beads. The specific antigen is covalently bonded to the latex 
particles and reacted with various dilutions of the homologous antiserum. 
The titer of the particular antiserum is defined as the last  dilution yielding 
complete agglutination. 
is provided as a reference. 
against the Mycoplasma increased from 1:59,000 to 1:177,000. With the 
anti-influenza preparation, the t i ter  remained the same (1:20,000). It is 
considered that the reactivity of both these antibody preparations w i l l  not 
The conventional complement fixation t i ter  (Tablc 21) 
The results indicate that the titer of the antisera 
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Table  20 
ANTISERUM PREPARATION F O R  MEMS 
Antibody Source  Titers 
Anti Mycoplasma 
Anti  Influenza 
C omme r c  ial 3 ( C F  1:8) 
Old 'IAMB'' Rabbit 59,000 ( C F  1 5 0 0 )  
Ant isera  
New 'IAMB" Rabbit 177,000 
and Goat An t i se ra  
C o m m e r c i a l  3 ( C F  1:16) 
Old "AMB" Rabbit 20,000 ( C F  1:500) 
Ant i sera  
New 'IAMB" Goat 20,000 
Ant i sera  
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diminish the sensitivity of the PIA test. 
sufficient quantities provides the capability to utilize a single preparation 
throughout the study, eliminating biological variations that w ould occur 
through the use of various preparations. 
In addition, the production of 
4.2 OPTIMIZATION OF PROCESS VARIABLES - SYSTEM SENSITIVITY 
Various conditions of the PIA reaction which affect the overall 
sensitivity of the test  were examined. 
the time interval of incubation; however, bead size,  reagent and sample 
mixing, bead concentration and the ionic strength of the suspending fluid were 
,also studied. 
I 
sized beads. 
most suitable (provided less  nonspecific agglutination), consequently, this 
class of beads was used throughout the remainder of the study. 
evaluation, in light of new methods for  sensitization or antigen pretreatment 
may indicate a reversal  of this trend. 
fluid (Glycine -Saline buffer) was evaluated by varying the concentration of 
both components. 
of both species reduced nonspecific agglutination. 
the reaction were varied from 10-50~0,  however, no conclusions can be made 
at  this time of the effect on the PIA sensitivity. 
mixing procedure w a s  modified. 
with a 6 x 10 mm glass tube. 
for the specific reaction to occur, while reducing evaporation that may attach 
reacted beads to the sides of the vessel. 
A concentrated effort, was placed on 
The effect of bead size w a s  evaluated with 1.01 p, 1. 10 P and 2 p 
Initial results indicated that the 1. 10 p latex particles were 
Further 
The ionic strength of the suspending 
Results indicated that a 5070 reduction in the concentration 
Bead concentrations in 
The sample and reagent 
The plastic reaction vessel was replaced 
The smaller size provides a greater probability 
4.2.1 INFLUENZA A2 HONG KONG VIRUS 
The purpose of these studies was to examine the effect of varying 
incubation time intervals and the use of high-quality antibody on PIA sensi- 
tivity. 
se ra ,  fractionated and purified by the techniques described in Appendix A, 
and attached by a heat fixation reaction. 
and utilized for the evaluation. 
The beads in this study were sensitized with the goat prepared anti- 
Several lots of antigen were prepared 
Table 21  represents the summarized data 
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Table 21 
SUMMARY, PIA SENSITIVITY DETERMINATIONS WITH THE 
MYXOVIRUS AS DETERMINED BY MEAN CLUMP SIZE 
Signal  Noise 
Concentrat ion ( E I D m / r n l l  (S) ( N) S - N  
30 min. Incubation 
lo; 
1°4 
1°3 
1°2 
lo 1 10 
3. 40 2 . 3 8 ,  1.02 
2.86 2.09 0.77 
2.39 2.12 0.27 
2.50 2. 18 0.32 
2. 31 2. 14 0. 17 
2. 32 2.20 0.12 
I Average Noise = 2. 18; r3" = 0.09 
60 min. Incubation 
l o 1  
3.49 2.56 0.93 
2.45 1. 84 0.61 
2. 69 2.08 
2.40 2.01 0.39 
2. 31 1.96 0 .35  
2.20 2. 15 0 .05  
Average Noise - 2. 19; C = 0.30 
* Represen t s  a s ingle  de te rmina t ion  
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for the two incubation intervals (30 and 60 minutes). 
graphically depict the data. 
mentation, from which the summary data were derived. 
Figures 11 and 12 
Table 22 is a listing of the original experi- 
The sensitivity of the PIA test, upon initial examination, appears 
t o  have decreased from 10-1 EID 
10 EDs0/  ml. 
sensitivity was due to  an increased efficiency in antigen production. 
sensitivity criterion used to evaluate the PIA technique against known quan- 
titation methods for the influenza virus is the egg infective dose, 5070 end- 
point (EID ). This is a valid unit of comparison if the percentage of in- 
fective to noninfective virus remains the same from passage to passage. 
During the initial passages while adapting the virus to an egg-host system, 
small quantities of infectious virus were produced, but in the process, 
large quantities of noninfective antigen were also produced. 
infective virus particles were not detected by the conventional EID 
50' 
being antigenic, they provided reactivity when measured with the PIA 
technique. As the number of passages increased, the virus became more 
adapted to  the egg-host system which was evidenced by the increasing in- 
fectivity t i ters  from lot to lot. 
became larger  while the total number of antigenic units remained relatively 
the same. The net effect of the increase of infective to  noninfective viruses 
i s  a decrease in PLA sensitivity when related to an infective unit measure- 
ment. This phenomenon would also prevent the absolute correspondence 
of the specific signal for a given virus concentration when different agent 
preparations a r e  used. 
from a single pass when making other variable evaluations. 
the sensitivity decrease was not a function of the "new antisera", an early 
pass (P3) was again examined. 
to  the previously reported values (lo-'), substantiating that the apparent 
loss  in sensitivity was a function of the antigen preparation. 
/ m l  (based on the initial studies) to  
2 50 
Closer examination found that the apparent decrease in 
The 
50 
These non- 
but 
The infective to noninfective virus ratio 
This can be circumvented by utilizing the virus 
To ensure that 
The sensitivity of the PLA was equivalent 
Even though this occurred, a comparison can be made a s  to 
the effect of the incubation time on the tes t  sensitivity. 
Figures 11 and 12 indicates that the sensitivity of the PIA technique in- 
creases  with increasing incubation time. 
for the incubation times a r e  a s  follows: (1) 30 min. =1. 8 x 10 
and (2) 60 min. 2 x 10 EID /ml. With a thorough optimization of the 
Examination of 
The sensitivity approximations 
2 EID /ml;  2 50 
50 
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Table 22 
PIA SENSITIVITY DETERMINATIONS WITH THE MYXOVIRUS AS 
DETERMINED B Y  MEAN CLUMP SIZE 
Myxovirus Signal Noise Incubation 
EID 50 /ml )  ( S  ) (N) S -N (minute  s)  
Concentrat ion Mean Clump Size Mean Clump Size T i m e  
10; 
1°7 
1°5 
1°5 
1°5 
O5 
1°4 
104 
1°4 
O4 
O4 
O4 
O4 
1°4 
1°4 
1°3 
1°3 
1°3 
1°3 
1°3 
1°3 
1°3 
1°2 
O2 
1°2 
1°2 
1°2 
1°2 
j 1°1 
lo 1 
1°1 
lo  1 
1°1 
lo  1 
1°1 
loo 3 
3. 18 
3.69 
3.33 
2 .24  
2. 83 
3. 58 
2. 81 
1.97 
2.33 
2.57 
2.99 
2.49 
2.81 
3. 13  
1. 31 
1.98 
1.97 
2.22 
2 .48  
2.40 
2.26 
2. 58 
2.97 
3. 18 
1. 82 
2.06 
1. 84  
2. 15 
2.48 
2. 31 
2.55 
3. 31 
1. 81 
2. 52 
1.98 
2. 61 
2 .34  
2. 81 
2.24 
2 .25  
2.08 
2.04 
1 .74  
3.04 
2. 38 
1. 65 
2. 18 
2.45 
2.10 
2.21 
1.96 
2. 31 
2. 87 
2. 50 
2. 30 
2.05 
1. 32 
1.57 
1. 61 
2. 17 
2.29 
2.01 
2.28 
2 .33  
2. 65 
2.11 
1. 58 
2. 19 
2.27 
2.04 
1. 86 
2.08 
2. 31 
2. 84 
1. 50 
2. 62 
2.09 
2 .44  
1. 82 
2.61 
2 .08  
2.48 
1.99 
2. 38 
1 .44  
0. 65 
0 .95  
0 .59  
0. 65 
1. 13  
0. 71 
-0.24 
0.37 
0 .26  
0.12 
-0.01 
0. 51 
1. 08 
-0.01 
0 .41  
0.  31 
0. 05 
0. 19 
0.39 
-0 .02  
0 .25  
0. 32 
1. 07 
0 .24  
-0 .13  
-0 .43  
0.11 
0. 62 
0. 23  
0 .24  
0 .47  
0.  31 
-0.10 
-0.11 
0. 16 
0. 52 
0 .20  
0. 16 
-0.23 
0.09 
-0.34 
30 
30 
30 
30 
30 
30 
30 
30 
30 
30 
30 
30 
30 
30 
30 
30 
30 
30 
30 
30 
30 
30 
30 
30 
30 
30 
30 
30 
30 
30 
30 
30 
30 
30 
30 
30 
30 
30 
30 
30 
30 
30 
1366 Page  73 
Table 22 (Continued) 
P I A  SENSITIVITY DETERMINATIONS WITH THE MYXOVIRUS AS 
DETERMINED B Y  MEAN CLUMP SIZE 
Myxovirus Signal 
Concentrat ion Mean Clump Size  
(EID 50/ml)  (SI 
3.49 
3.04 
2.44 
2.87 
2.20 
1.77 
2.40 
2.69 1 104 4.23 
2. 81 
3.00 
2 .04  
1.42 
2. 52 
2.70 
2.41 
2.68 
2. 31 
2.20 
4. 27 
2.44 
1.93 
2.12 
2.47 
0.55 
2. 18 
2.35 
3. 08 
2.04 
2.26 
2. 97 
3. 27 
2.35 
1.29 
2.01 
2. 32 
2. 36 
2.26 
1. 58 
3.85 
3.73 
2.09 
1. 67 
1. 88 
2.08 
2. 19 
2. 15 
Noise Incubation 
( N) S -N (minutes)  
Mean Clump Size  Time 
2.56 0.93 60 
1.85 1. 19 60 
1.72 0. 72 60 
1. 72 1. 15 60 
1.57 0. 63 60 
2. 24 -0.47 60 
1.96 0.44 60 
2.37 0. 32 60 
2.64 1.59 60 
2.44 0 .37  60 
2.26 0. 71 60 
1 .43  0. 61 60 
1.28 0. 14 60 
1. 89 0. 63 60 
1. 68 1.02 60 
1.93 0.48 60 
1. 96 0. 72 60 
2. 17 0. 14 60 
1. 82 0. 38 60 
2. 64 1. 63 60 
2.64 -0.20 60 
1. 72 0 .21  60 
1.73 0 .39  60 
1. 69 0. 67 60 
1. 60 -0.05 60 
1. 66 0. 52 60 
2. 18 0.17 60 
2.37 0.71 60 
2.61 -0.56 60 
1.92 0.34 60 
2.53 0 .44  60 
2.73 0.54 60 
1.49 0. 86 60 
1.27 0.02 60 
1.92 0.09 60 
1. 87 0 .45  60 
1.98 0. 38 60 
1.66 0. 60 60 
1. 32 0.2 6 60 
3. 51 0.34 60 
2. 50 1. 23 60 
1. 72 0 .37  60 
1. 72 -0.05 60 
1.57 0. 31 60 
1. 78 0. 30 60 
1. 64 0 .45  60 
1.69 0.46 60 
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Table 22 (Continued) 
PIA SENSITIVITY DETERMINATIONS WITH THE MYXOVIRUS AS 
DETERMINED B Y  MEAN CLUMP SIZE 
.Myxovirus Signal Noise Incubation 
Concentrat ion Mean Clump Size  Mean Clump Size  Time 
( EID 50/ml)  ( S )  (N) S -N (minutes)  
10; 2 .34 1.91 0 .43  60 
2.74 2.29 0.45 60 
1. 69 1.91 -0.22 60 
2.68 2.29 0.39 60 
2.55 1. 88 0.67 60 
2. 63  2.20 0 .43  60 
2.09 1.97 0.12 60 
2.23 1. 60 0. 63 60 
2.34 1.94 0.40 60 
2.12 1.90 0.22 60 
3. 84 3 .48  0. 36 60 
2 .44  2.23 0 .21  60 
1. 76 1. 78 -0.02 60 
1.65 1. 8 3  -0. 18 60 
2.44 1. 73 0.71 60 
1.47 1. 51 -0.04 60 
1.82 1.99 -0.17 60 
1. 88 1. 69 0. 19 60 
1.94 1. 88 0.06 60 
2.55 1. 89 0.66 60 
2. 60 2.33 0.27 60 
2.75 1. 98 0.77 60 
2.37 2.53 -0. 16 60 
1.98 1.95 0 .03  60 
1.98 2 .03  -0.05 60 
1. 85 1.97 -0.12 60 
3.46 4. 78 -0. 32 60 
2.77 2.47 0. 30 60 
2.04 2.42 -0. 38 60 
2. 18 2.61 -0 .43  60 
1. 82 1.93 -0.11 60 
2.48 2 .74  -0.26 60 
2.69 3.11 -0.42 60 
1°2 
1°2 
1°2 
1°2 
1°2 
1°2 l o 2  
102 
1°2 
3 
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reaction condition variables, the sensitivity should approach the desired 
range of 10' - 10 EID 
infective to noninfective virus). 
1 /ml (even in a preparation with a high ratio of 
50 
Propagation Effort and Antigen Purification 
Efforts were continued to characterize the Myxovirus (influenza 
A2 Hong Kong strain). A ten-fold volume concentration (with Diaflo ultra- 
filtration apparatus) on preparations P5, P5-1A and P5-1B w a s  completed. 
The results a r e  listed in Table 23. 
Table 23 
Effect of Volume Concentration - on HA Activity and Egg Infectivity 
Quantity (ml) EID50/ml HA 
Passage Before After Before Af te r Before After 
2 60 25 3.2xlO 3 . 2 ~ 1 0  1:64 1:256 
670 65 3x1 0 3.2xlO 1:128 1:024 
p5 
7 
P5-1A 
P5-1B 700 not done not done 1: 128 1: 1024 
The 700 ml harvest of P5-1B was divided into aliquots of 500 and 
200 ml. 
residual of the 500 ml aliquot w a s  adsorbed with barium sulfate-sodium 
oxalate and eluted in gelatin fortified phosphate buffer. This eluate was 
divided into two parts. One was centrifuged against a 3-60010 sucrose gradient 
at 37,000 rpm for 90 minutes (SW #39 swinging bucket rotor, Model L2 Spinco 
ultracentrifuge). The other part  was spun against a cushion consisting of 
three layers: 1 ml each of 60, 40 and 30% sucrose. The same conditions 
and time of spin were used for  this aliquot a s  for the first.  
Both parts were concentrated tenfold by Diaflo ultrafiltration. The 
The 200 ml aliquot of the original material w a s  Diaflo ultrafiltered 
through three changes of phosphate buffer, pH 7.2.  
from 1:512 for the f i rs t  concentration to 1:256 after the third change. 
protein of the original harvest of P 
oxalate adsorption and elution, the protein content was 0. 75 mg/ml. The 
eluate fluid (containing gelatin, which gave a positive Lowrey test) had a 
protein content of 0.5 mg/ml. The barium sulfate adsorption technique 
removes most of the protein from allantoic fluid concentrated by Diaflo 
ultrafiltration. 
The HA deteriorated 
The 
was 2 mg/ml. After barium sulfate- 5-1B 
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A typical profile of the density gradient and cushion centrifugation 
are listed in Table 24. 
Table 24 
Myxovirus Purification by Density Gradient and Cushion Centrifugation 
Density Gradient Cushion 
3% - 6070Sucrose 30, 40 and 6070 Sucrose (1 ml each) 
Inc r e  as ing 
Density 
! 
i 
v 
Fraction 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
HA 
l:o 
1:2 
1:512 
1:512 
1:64 
1: 16 
1:16 
1:8 
1:32 
1:32 
Inc rea s ing 
i 
Density F raction 
I 1 I 
2 
8 
9 
10 
11 
12 
HA 
l:o 
1 :o 
1:2048 
1:8192 
1: 1024 
1: 1024 
1:1024 
1: 128 
1:32 
l:o 
l:o 
1:256 
In all cases, the top most portion of each tube of the sucrose 
It is most probable that this HAactivity is revealed some HA activity. 
due to the presence of incomplete virus and/or viral protein. Protein 
determinations were not conducted on the fractions from the gradients 
because the size of each sample w a s  too small. 
$4.2.2 MYCOPLASMA PNEUMONIAE 
Sensitivity Studies 
The purpose of these studies, as with Myxovirus, w a s  to examine 
the effect of high-quality antibody and varying incubation times on the 
sensitivity and reliability of the PIA test. 
antibody used to sensitize the bead preparation is described in Section 4. 1. 
The characterization of the 
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The summarized results of the sensitivity determinations at the 
Table 26 is a listing of three incubation times are described in Table 25. 
the individual experiments, from which the summary data were derived. 
The sensitivity of 100 CFU/ml is at  least one order of magnitude lower than 
achieved during the initial studies with this organism. The increases in 
sensitivity is quite dramatic, and can be primarily attributed to the improved 
quality of the antiserum. 
The Mycoplasma antigen used for this tes t  ser ies  was frozen and 
thawed several times before use. 
increased sensitivity. 
to  break up the cell wall of the organism into smaller but more numerous 
This procedure also contributed to  the 
The physical action of the freeze-thaw cycle serves 
) fragments. This effectively increases the amount of reactive particulates. 
To further increase the test sensitivity, more vigorous sample fragmentation 
may be required. The scatter in the data indicates that the fragmentation 
process (under these conditions) was not consistent in the quantity of par- 
ticulates formed per organism. 
controlling the conditions which a r e  utilized for cell disruption. 
Reliability can be increased by closely 
Conclusions cannot be drawn regarding the effect of incubation 
time on the test  sensitivity. 
reestablished before this type of comparison can be performed. 
log increase in sensitivity demonstrates the successful preparation of high- 
quality antibody. It is anticipated that special methods in antigen pretreat- 
ment will provide the reliability and sensitivity required to  utilize the PIA 
Linearity (signal vs. concentration) must be 
The one 
tes t  a s  an environmental monitor for Mycoplasma pneumoniae. 
Antigen Production and Purification 
A total of 11 l i ters  of M. pneumoniae were produced since the -
las t  reporting period. 
assayed a t  an average t i ter  of 5 x 10 
further reduced in volume 10 fold. 
concentrate. 
The entire volume was concentrated 50 fold and 
8 
No assay was conducted on the final 
CFU/ml. The resultant 220 ml  was 
The - M. pneumoniae was routinely monitored for purity by growth 
inhibition with M. - pneumoniae antiserum impregnated filter paper discs, 
growth on PPLO agar containing methylene blue and reduction of 2,3,5- 
triphenyltetraz olium chloride . 
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Table  2 5 
SUMMARY, PIA SENSITIVITY DETERMINATIONS WITH THE 
MYCOPLASMA AS DETERMINED B Y  MEAN CLUMP SIZE 
Signal Noise 
Concentration (CFU/ml)  (SI ( N) S -N 
.- 
30 min. Incubation 
lo5* 2. 19 1. 68 0.51 
lo3 
lo2  
10 
4. 16 3. 76 0.40 
4. 50 3. 66 0.84 
3 .  72 3 .  61 0.11 
60 min. Incubation 
lo7  1. 86 1. 63 0.23 
l o5  3. 65 2. 72 0.93 
10 3. 30 2. 76 0.54 
l o 2  2.75 2. 61 0. 14 
10 3.64 2. 81 0. 83  
90 - 120 min. Incubation 
lo7' 2. 41 1.91 0. 50 
2.27 1. 82 0.45 
l o 3  3.  17 2.02 1 .  15 
2.65 1. 89 0. 76 
10 2. 38 1.87 0. 51 
10556 
102* 
1 Represen t s  a s ingle  de te rmina t ion  
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Table 26  
PIA SENSITIVITY DETERMINATION WITH THE MYCOPLASMA AS 
DETERMINED B Y  MEAN CLUMP SIZE 
Mycoplasma Signal Nois e Incubation 
Concentrat ion Mean Clump Size  Mean Clump Size  Time 
(CFU/ml )  (SI ( N) S - N  (minutes)  
10: 
1°3 
1°2 
lo 1 
1°7 
IO5 
1°5 
1°5 
1°5 
1°5 
O5 
1°3 
1°3 
1°3 
1°3 
1°3 
1°3 
1°3 
1°3 
1°3 
1°3 
1°2 
O2 
O2 
1°2 
1°1 
1°1 
1°1 
1°1 
1°1 
1°1 
1°1 
;:; 
10 
10; 
E; 
3 
1366 
2. 19 
4.21 
4. 16 
4. 24 
4. 77 
4. 10 
3. 34 
2.34 
1. 72 
1.52 
4.05 
2. 17 
5 . 3 4  
1. 62 
1. 72 
7.00 
6. 52 
4.59 
2. 08 
2.46 
3. 09 
2 .35  
2.29 
1. 52 
1. 62 
6. 52 
2.45 
4. 72 
1.77 
2. 09 
5. 29 
3.96 
1 .94  
5.48 
6.22 
2. 87 
4. 51 
2. 14 
2.23 
1.79 
1. 68 
3.08 
4.45 
3. 58 
3. 64 
3. 56 
3. 67 
1. 80 
1. 56 
1. 14 
2.77 
1 .79  
3.10 
1. 40 
1. 40 
5. 86 
5.77 
3. 38 
1 .74  
2.53 
2 .54  
1. 67 
1.77 
1. 64 
1. 65 
4.90 
2. 52 
4. 32 
1. 84 
1.77 
3. 58 
3.22 
1 .  67 
4. 51 
4. 62 
2. 61 
3.06 
1. 82 
1. 58 
1 .44  
0. 51 
1. 13  
0 . 6 6  
1. 13 
0.54 
-0.33 
0 .54  
0. 16 
-0.02 
1.28 
0. 38 
2.24 
0.22 
0.  32 
1. 14 
0 .75  
1 .21  
0 . 3 4  
-0 .07  
0 .55  
0. 68 
0. 52 
-0 .12  
-0 .03  
1. 60 
0 .40  
0. 32 
1. 71 
0 . 7 4  
0 .27  
0.97 
1. 60 
0 .26  
1.45 
0. 32 
0 .65  
0 .35  
-0.29 
-0.07 
-0.07 
30 
30 
30 
30 
30 
30 
30 
60 
60 
60 
60 
60 
60 
60 
60 
60 
60 
60 
60 
60 
b0 
60 
60 
60 
60 
60 
60 
60 
60 
60 
60 
60 
60 
60 
60 
60 
60 
60 
60 
60 
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Table 26 (Continued) 
PIA SENSITIVITY DETERMINATION WITH THE MYCOPLASMA AS 
DETERMINED BY MEAN CLUMP SIZE 
My c opla s ma Signal Noise 
Concentrat ion Mean Clump Size  Mean Clump Size 
10; 2.41 1.91 0. 50 
2. 27 1.82 0.45 
2. 56 1. 70 0.86 
3. 78 2.44 1 .34  
2. 65 1. 89 0. 76 
2.42 1. 89 0 .53  
2.35 1. 76 0.59 
(CFU/ml )  (S 1 (N) S-N 
1°3 
1°3 
1°2 
lo  1 
1°1 10 
Incubation 
Time 
(minutes)  
90 - 120 
90- 120 
90- 120 
90-120 
90-120 
90- 120 
90-120 
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4.3 SPECIFICITY OF THE IMPROVED ANTISERA 
The specificity of the improved antisera for both the myxovirus 
and the Mycoplasma was tested with three heterologous organisms. 
Table 27 is a summary of the results obtained from the c ross  reactivity 
tests. 
specificity studies. 
Table 28 is a compilation of the individual experiments in the 
The results indicate that there was no significant 
cross  reaction between the improved antisera and the heterologous agents. 
However, the limit of specificity cannot be determined since closely re -  
lated organisms were not tested. 
would be anticipated when antigenically similar organisms a r e  tested 
Certain amounts of c ross  reactivity 
') with a single antiserum. 
4.4 CLINICAL SAMPLE TESTING 
Four contractually required clinical samples were received from 
NASA in addition to five additional samples that were to  be tested if possible. 
Each sample was assayed by the PLA undiluted, or  a t  a 1 : l O  dilution. 
summary results a r e  shown in Table 29. (Actual experimental data a r e  in 
Table 30). 
while samples E-H were negative. 
positive result. 
the conventional methods. In the conventional procedure, aliquots of the 
unknowns were aseptically injected in the amniotic sac of 11-day old embry- 
onated hens eggs. 
and tested for the presence of virus by screening for hemagglutination activity. 
Samples A and D demonstrated HA activity, while samples B and C were 
negative. 
not obtained. 
however, 
The 
The first four samples (labeled A, B, C, and D) were positive, 
Sample J demonstrated an intermediate 
The PIA results do not correspond to results obtained by 
After 72 hours, the amniotic fluids were harvested 
Hemagglutination inhibition t i ters  for the positive samples were 
These results do not correspond completely with the PIA data; 
variations in the constituents of the sample suspending fluid most ' probably account for  this lack of correlation. It is felt that correlation be- 
tween the two methods is a simple attainable goal, to be achieved through 
the development of a suspending fluid which is most compatible with the 
PLA test. 
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Table 27 
CROSS REACTIVITY DETERMINATIONS USING AVERAGE SIGNAL 
MINUS NOISE O F  MEAN CLUMP SIZE 
Sensi t ized Beads 
Agent C once n t r a t i  on Mycoplasma Myxovirus 
4 Mycoplasma 10 C F U / m l  fG-1 -0 .  19 
-0.06 i o  4 E I D ~ ~ / ~  Myxovirus 
-0. 31  -0. 13  10 4 TCID50/ml I Adenovirus 
Herpesv i rus  lo4 m / m l  -0.23 -0.06 
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Table 28 
CROSS REACTIVITY DATA SUMMAoRY 
INCUBATION 60 MINUTES AT 40 C 
Antibody 
Sensi t ized Antigen f o r  
Beads C r os s Reaction 
My c opla s ma Mycoplasma 
lo4  C F U / m l  
Ave. 
Myzovirus 
10 EID50 /ml  
Ave. 
Ad4 n ov i r u s 
10 TCID50/ml 
Ave. 
Hezpe s v i r u s  
10 P F U / m l  
Ave. 
Myxovirus M yzov i r u s 
10 EID50/ml 
Ave. 
Myc oplas ma 
lo4 C F U / m l  
Ave. 
Adz novir u s  
10 TCID50/ml 
Ave. 
He pesv i rus  
10 PFU/ml 4 
Ave. 
Mean ClumP S ize  
Signal 
3. 63 
3.08 
2.41 
2. 56 
1.97 
2. 58 
2. 56 
1. 82 
2. 58 
2.91 
2. 16 
2. 81 
2. 62 
2.59 
2. 15 
1. 85 
2.87 
2. 66 
2.08 
2.02 
2. 32 
2.27 
2. 15 
2. 03 
Noise 
2.22 
2. 50 
2 .54  
2. 58 
1.99 
2. 85 
2. 76 
2. 27 
2. 89 
3.28 
2. 18 
2.26 
1.75 
1.97 
2.60 
2. 17 
2. 69 
2.37 
2. 27 
2. 52 
2.76 
2 .34  
1. 98 
1.92 
S -N 
1 .41  
0.58 
lxq 
-0. 13 
-0.02 
-0.02 
I------ 0 .061  
-0.27 
-0.20 
-0.45 
-I_-_ 
[X-iii ---_I 
-0.31 
-0.37 
-0.02 
1-0.23 1 
0.55 
0. 87 
0.62 
I-- ----__ 
1+0-68] I".- - 
1- 
-0.45 
-0.32 
0. 18 
0. 29 
-0. 19 
-0.50 
! -0. 13 
-0 .44  
-8.07 
0. 17 
0.11 
! -0 .06 1 I - -  
i- ----_I 
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Table 29 
SUMMARY, PIA EXAMINATION OF CLINICAL SAMPLES* 
Signal Noise 
Unknown Mean Clump Size  Mean Clump Size  
Designation (SI ( N) S -N 
A 
B 
C 
D 
1 E 
F 
G 
H 
J 
2.54 
2. 38 
2.40 
2. 64 
1. 18 
1. 28 
1. 2 4  
1. 34 
1. 83 
1. 36 
1. 35 
1.26 
1.26 
1. 24 
1. 29 
1.25 
1.25 
1. 25 
* Average  S-N at 60 minutes  incubation, Sample undiluted. 
1. 18 
1.02 
1. 14 
1. 38 
-0.06 
-0.01 
-0.01 
0. 09 
0. 58  
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Table 30 
PIA EXAMINATION OF CLINICAL SAMPLES 
Signal Noise Incubation Dilution 
Jnknown Mean Clump Size Mean Clump Size Time fo r  
)e s ignation ( S  1 ( N) S-N (minutes)  T e s t  
A 2.46 1. 32 1. 14 60 Undiluted 
A 2.62 1.40 1.22 60 Undiluted 
A 
A 
A 
B 
B 
B 
C 
C 
C 
C 
D 
D 
D 
D 
E 
E 
F 
F 
G 
H 
J 
J 
1.37 
1. 30 
1.48 
2. 19 
2. 56 
1.74 
1.55 
2.26 
2.53 
1. 42 
1. 52 
2. 64 
2. 30 
1. 69 
1.55 
1. 18 
1.29 
1. 28 
1. 34 
1. 24 
1. 26 
1.34 
1. 33 
1.97 
1.69 
1.46 
1.44 
1.59 
1. 30 
1. 40 
1. 51 
1. 58 
1. 13 
1. 38 
1.33 
1. 60 
1. 26 
1.47 
1.49 
1.46 
1. 24 
1.28 
1. 29 
1. 28 
1. 25 
1. 25 
1.25 
1.33 
1. 16 
1.33 
-0.09 
-0. 14 
-0.11 
0. 89 
1. 16 
0. 23 
-0.03 
1. 13 
1. 15 
0. 09 
-0.08 
1. 38 
0. 83 
0. 20 
0. 09 
-9. 06 
0.01 
-0.02 
0. 06 
-0.01 
0.01 
0. 09 
0 . 0 0  
0. 81 
0. 36 
60 
30 
180 
60 
60 
60 
180 
60 
60 
60 
180 
60 
60 
60 
180 
60 
180 
60 
60 
60 
180 
50 
180 
60 
60 
1: 10 
Undiluted 
1:lO 
Undiluted 
Undilu t e d 
1: 10 
1: 10 
Undiluted 
Undiluted 
1: 10 
1: 10 
U ndilut e d 
1:lO 
1: 10 
1: 10 
Undiluted 
1: 10 
Undiluted 
1: 10 
Undiluted 
1: 10 
Undiluted 
1: 10 
CJndilute d 
Undiluted 
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4.5 
4.5.1 MANUAL READOUT SYSTEMS 
Terminal Dilution Methods 
EXAMINATION OF READOUT TECHNIQUES FOR THE PIA TEST 
The most common method of quantitating the latex agglutination 
reaction involves the observation of an all-or-none reaction (agglutination) 
using sequential dilutions of either antigen or antibody to provide an end- 
point. 
body titers. 
particles to form agglutinates is identified a s  the titer. 
The technique has  been extensively used for measurement of anti- 
The highest dilution of antibody that reacts with antigen-coated 
In practice, reaction 
i 
1 sensitivities and specificities have been found to be a t  least equal to other 
more conventional serological tests. 
advantage in this regard. Since one of the reactive species (usually antigen) 
is adsorbed on a particle, its size is effectively that of the carr ier .  Thus, 
fewer effective antigen-antibody combinations a r e  needed to  produce a vis- 
ible or otherwise measurable reaction than in conventional precipitation or  
agglutination methods . 
The latex method has an inherent 
Microscopic Method 
Microscopic readout of the PLA test  was used throughout the MEMS 
program. 
microscopic field and determining the number of beads per clump. 
ticle size distribution analysis was then made on the results of these data. 
This analysis resulted in a readout in which the measurement of all the 
clumps was reduced to a single value termed the mean clump size. 
derivation of mean clump size is shown in Appendix B. 
This readout involved counting the number of clumps in each 
A par- 
The 
A disadvantage of the microscopic particle size distribution 
method is the time required for  performing and reading the agglutination 
reaction. 
step toward producing a method of great practical utility for detecting 
agent antigen in clinical samples. 
Instrumentation of the readout phase is seen a s  the las t  logical i 
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4.5.2 S EM1 - AU TOMA TED REA DOU T SYSTEMS 
Electronic Particle Counters 
Electronic sensing zone instruments have been widely used in 
recent years for quantitation of particle numbers and size distribution of 
microbial populations, red and white blood cells, etc. 
In this study, it w a s  found that volume distribution measurements 
made by the Coulter Counter were seriously distorted, the frequency of 
large volumes being greatly exaggerated. The causes of these distortions 
were not attributed to any inherent nonlinearity in the signal amplification, 
> o r  to a physical particle coincidence count in the sensing zone, but to a 1 combination of electronic coincidence e r r o r s  in the amplifier and a more 
serious effect of wide distributions of transit times through the sensing 
zone. 
A Celloscope w a s  used in our laboratory to determine the feasi- 
bility of automating the readout by counting the clumps using the conductometric 
method. 
Counter principle (see diagram in Figure 13). 
placed in a solution containing the particles. 
ductive solution, an electrode is placed inside the tube and in the sample 
solution. Current then travels from the solution outside to the solution 
inside the tube through a 4 8 ~  orifice. 
orifice, a steady state current i s  maintained through the hole. However, i f  
a particle of sufficient size passes through the orifice, the current flow is  
restricted for the duration of the passage. 
which is proportional to particle size, is then measured a s  an  impulse and 
recorded through suitable electronics on a counter and printer. 
The Celloscope is a particle counter that works on the Coulter 
A tube with a 48 p hole is  
The tube is filled with a con- 
If no particles pass through the 
This restriction of current flow, 
Liquid passes from the outside to the inside of the tube by applying 1 
a vacuum to the tube. 
orifice can be regulated by regulating the vacuum. 
and the subsequent amplification can be regulated by the appropriate controls 
present in the machine. 
The flow rate of the sample solution through the 
The amount of current 
Preliminary runs were made with the Celloscope in which sensi- 
tized beads were mixed with the appropriate antigen and the resulting 
mixtures counted on the particle counter. 
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VACUUM 
Figure 1 3  - Schematic of Coulter Principle 
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Page 89 
Figure 14 represents a preliminary determination of the feasibility of 
the Celloscope to monitor the PIA reaction. The control had a mean 
clump size of 1.45 while the sample w a s  4.01, as measured with the 
PIA (manual readout). 
be utilized in this application, but the lower sensitivity limits must be 
determined. 
The initial data indicate that the Celloscope can 
Further examination w i l l  have to be performed on the variables 
involved in conductomatic counting before a final decision is made. 
Light Scattering Particle Counters 
A second method examined was a light scattering device developed 
,by Royco. 
light intensity across  a 200 micron tube which contains a solution of particles 
moving in a single direction. 
directly proportional to the size of the particle or particles that pass through 
the tube. 
control and sample(same preparation analyzed by the Celloscope). 
curves represent the distribution of the particle sizes in the different 
channels of the analyzer. At the clump sizes that were present in the 
control and sample, the Royco was dramatically able to differentiate between 
the two. The simplicity of operation and the rapidity of the data presentation 
were two inherent advantages with this device. 
further testing whether smaller differences between control and sample can 
be detected. 
This device (Figure 15) operates by measuring the change in 
The amount of change in light intensity i s  
The data presented in Figure 16 show the difference between the 
The 
It remains to be seen on 
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Automated Microscopic Method 
The system shown schematically in Figure 17 demonstrates the 
third method of counting that w a s  examined. 
microscope for the initial magnification. 
stage of the microscope and its image is  detected by the video camera. 
This signal is then processed by computer modules and displayed on the 
TV screen monitor. 
the eyepiece of the microscope. 
This system utilizes a 
A sample is placed on the 
The sample may also be viewed directly through 
Selected parameters of the particles in the sample a r e  measured 
by computer modules and presented in alphanumeric form at  the top of 
the monitor screen. Detailed measurements can be made on individual 
particles as well as entier fields. 
The counting of particles is controlled by a logic that follows the 
rules for manual counting, leading to statistically valid results. 
advantage of this system is that rapid operation requires only minimum 
technical and manipulative skills. 
system is the need for a microscope that has to be focused fo r  each sample. 
Maintaining the microscope in focus and field selection a r e  performed 
manually. 
The 
The current disadvantage with this 
Table 31 presents the desirable properties of a counting system 
f o r  the PIA test and rates each counting system against these properties. 
The selection of the optimum automated readout system must await 
further evaluation. 
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FIGURE 17 - SCHEMATIC OF AUTOMATED MICROSCOPE READOUT 
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Table 31 
PRELIMINARY EVALUATION - AUTOMATED READOUT DEVICES 
Readout Response Ease of Particle 
Method Time Opera t i  on Sensitivity* Size Range 
Terminal Dilution 
) PIA 
Electronic Sensing 
2 one (C ellos c ope) 
Light Scattering 
(ROY C 0) 
A ut oma t e d 
Micros c ope 
(Millipore) 
4-18 hours 
15 minutes 
2-5  minutes 
2 -5 minutes 
1 minute 
fair 
fair  
good 
excellent 
good 
2 4 10 - 10 EID50/ml 
1 - 10 EIDSO/ml 
10-100 EIDSO/ml** 
10 - 100 EID50 /ml+y' 
10 - 100 EIDSO /rnl*$' 
* Infectivity of Influenza A Hong Kong virus expressed a s  
egg infective doses - 50$endpoint per ml (EIDSO/ml) 
These values represent the results of a limited number of 
experiments, where lower sensitivities were not evaluated. 
A sensitivity and reliability comparison among these three 
methods or in relation to the manual PIA method cannot be 
accomplished with these data. 
the methods a r e  applicable and merit extensive analysis. 
** 
These results do indicate that 
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5 .0  CONCLUSIONS AND RECOMMENDATIONS 
The PIA test has been evaluated for 5 viruses and 1 Mycoplasma 
species. 
make the test useful for ecological monitoring. 
PIA test for Mycoplasma has not as yet reached its maximum, but 
indications are that the sensitivity can be raised to a level necessary 
to permit ecological monitoring. 
The sensitivity of the test  for the 5 viruses is high enough to 
The sensitivity of the 
The PIA test has been shown to be a feasible method to rapidly 
It detect and identify small quantities of virus in aqueous suspensions. 
has a lso been shown that the sensitivity of the PIA test is dependent on a 
number of factors. 
t i ter ,  and 3) suspending fluid. 
’ 
Some of these factors are:  1) antigen size, 2 )  antibody 
1 
Conventional methods for identification of viruses involve such 
methods as the HA, HA1 and CF techniques. 
relatively large amounts of viral  antigen for their successful operation. 
These methods required 
Conventional methods of isolation involve the use of living hosts. 
In such cases,  the material being isolated and detected is an infective 
unit. The PIA test ,  on the other hand, does not detect infective units as 
such, but rather antigenic units. These antigenic units may be of much 
smaller size than the infective units (i. e. , viral  structural components), 
In some cases,  these units may be two or  three orders  of magnitude more 
numerous in a virus preparation than the infective units themselves. 
is due to the inefficiency of the cellular propagation process itself or to 
the results of environmental inactivating s t resses .  
that provides the unique sensitivity of the PIA test. 
This 
It is this amplification 
W i t h  larger antigens such as the Mycoplasma, the detection of 
) the antigenic unit versus the detection of the infective entity can work 
to a disadvantage. 
fewer defective antigens in solution than occur in virus multiplication. 
As a result  of fewer free antigenic particulates, it becomes necessary 
to break up the larger  agent into smaller pieces, each of which w i l l  
serve equally w e l l  as antigen for the PIA test. 
The multiplication of Mycoplasma apparently leaves 
The amount of antibody that can be placed on a latex particle 
represents an  important element in the overall sensitivity of the PIA 
system. The amount of specific antibody on a sensitized bead can be 
1366 
increased in two ways :  1) by an increase in the amount of gamma globulin 
on the bead, and 2) by an increase in the purity of the antibody. 
es t  potential improvement is in increasing antibody purity. Examinations 
in our laboratory have shown that both the reliability and the sensitivity of 
the test can be increased by a proportionate increase in antibody titer. 
sensitivity of the PIA test  for Mycoplasma pneumoniae increased one order 
of magnitude by increasing the C F  t i ter  of the antibody by a factor of approxi- 
mately 20 .  
The great- 
The 
The suspending fluid of the virus is also important in determining 
the overall sensitivity of the PIA test. One of the factors that affect 
) detection sensitivity is the background or  noise level. The nonspecific 
agglutination of the sensitized particles is due to a net attractive electro- 
static charge comprised of the surface charge (due to protein) plus the 
charge on the polystyrene bead itself. By suitably varying the pH and 
ionic strength of the reaction mixture, one can decrease nonspecific 
agglutination while maximizing specific clumping. 
In summary, the overall sensitivity of the PIA test for the viruses 
has been shown to surpass or  equal the results obtained with conventional 
methods. 
among the agents tested. 
specimen determinations has been established. 
evaluated for automating tne readout, all of which demonstrated com- 
patibility with the P I A  method. 
Specificity studies have indicated no significant c ross  reactivity 
The feasibility of the PIA test fo r  clinical 
Three systems were 
The following tasks a r e  recommended s o  that the value of the 
PIA test  (high sensitivity and short response time) can be applied, not 
only as an  ecological viral monitor, but as a method able to perform real  
time diagnostic tests. 
1. Continue reagent improvements to increase test  sensitivity 
and specificity. 
Optimize the process variables to increase test  sensitivity 
and reliability. 
Select and optimize a suitable readout system. 
2. 
3. 
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4. Develop a breadboard device, incorporating the readout 
system with sample processing hardware. 
Expand the utility of the PIA test to milltiagent analysis, 
bacterial detection and antibody quantitation. 
5 .  
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APPENDIX A 
ANTIBODY CHARACTERIZATION AND PURIFICATION 
HEMAGGLUTINATION (HA) USING THE MICROTITER METHOD* 
1. Place 50 p1 of standard PBS in each of 12 wells cf a V-bottomed 
Mic rotiter plate. 
2. Add 50 p1 of stock virus to the first well and mix. 
3. Using 50 pl diluters, serially dilute the first 11 wells. 
4. To each tubeadd 50 p l  of a 0 .5  per cent erythrocyte suspension (in PBS). 
i 
5. Cover the Microtiter plate, shake gently and incubate 20-45 min. at 37OC. 
6.  Examine the bottom of the wells for agglutination and record as follows: 
t bottom of well covered by a layer of finely clumped cells 
of granular appearance; complete agglutination. 
f a slight ring of partially agglutinated cells. 
0 A small, sharply outlined button of cells in the center of the 
tube; no agglutination. 
7. The virus HA t i ter  is the reciprocal of the highest dilution of virus 
causing t (complete) agglutination. 
*E. H. Lennette, 1964. General Principles in  Diagnostic Procedures for  
V i r a l  and Rickettsial Diseases (3rd Ed. ). Am. Pub. Health Assoc: New York, 
p. 57 
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1. 
2. 
3 .  
5. 
6. 
7. 
8.  
HEMAGGLUTINATION INHIBITION (HAI) USING THE MICROTITER METHOD 
Inactivate all sera at 56OC for 30 minutes. 
Add 25 p1 of PBS to  each well, except the f i rs t  well. 
Add 25 p l  of test se rum diluted 1:8 to the lst, 2nd and last well (serum 
c ont r o 1 s ) . 
Using 25'pl diluters, begin with the 2nd well and serially dilute the 
contents of each well except the last. 
Add 25 p1 of an antigen dilution containing 4 HA units to each well 
except the serum control. 
Shake gently and allow to stand at  room temperature for 30 minutes. 
Add 25 pl of 0 .5  per  cent erythrocytes in PBS (chicken, sheep o r  
human) to each well. 
room temperature. 
Shake gently and allow to stand for 1 hour at 
Read for agglutination patterns, a s  for the HA procedure. 
HA1 t i ter  is the reciproczl of the highest dilution yielding complete 
negative (0) agglutination. 
The serum 
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JIA - IIAI TEST REAGENTS 
1. Phosphate buffered saline (PBS) pH 7 .2 ,  with 0.01 M phosphate. 
2. Erythrocyte suspension - 0.5% washed chicken, sheep o r  human 
red blood cells in PBS.  
3.  Antigen - 4 hemagglutinating {HA) units in 25 pl of PBS. 
unit is the highest twofold dilution of antigen which completely 
agglutinates a 0.570 suspension of red blood cells. 
One HA 
1 
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COMPLEMENT FIXATION TEST 
A. H emo ly s i n T it r at io n 
1. Add 50 p l  of the appropriate hemolysin dilution to each 
well in the ser ies .  
2. Add 50 p1 of guinea pig complement diluted 1:30 to each well. 
3.  Add 50 p1 diluent to each well. 
i 
4. Add 50 p1 of 2 percent sheep cells to each well. 
5. Incubate 1 hour at 37OC. 
6. Read for cell lys i s .  
B. Complement Titration 
1.  Add 50 pl  of the appropriate corr,nlement dilution to 
each well in the series.  
2.  Add 50 p1 of diluent to each well. 
3 .  Add 25 p1 of antigen (2 units) to each well. 
0 4. Incubate 1 hour a t  37 C .  
5. Combine equal volumes of hemolysin (2 units) and 2% sheep 
cells, let react for 15 minutes. 
) 
Add 50 pl to each well. 
6.  Incubate 1 hour at  37OC. 
7. Read for cell .lysis. 
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HEMOLY SIN TITRATION 
1 
Well Hemolysin Complement Diluent Sheep Cells 
No. (pl) (dilution) 1:30 (PI) (P1) 2% (P1) Incubate -
1 c 
2 
3 
4 
I S  
6 
7 
8 
9 
10 
1 : 1000 f 
1:2000 
1:3000 
1 :4000 
1 :5000 
1 :6000 
1 :80OO 
1:10000 
1 : 12000 
1: 16000 
i C 1 hr i ; 37OC 
1 
COMPLEMENT TITRATION 
Well Complement Diluent Ag. 2 units 
No. (& (dilution) ( ~ 1 )  (PI 1 Incubate %3RB C In cub at e 
1 
2 
3 
4 
G 
7 
8 
9 
10 
I: 1: 10 
1:15 
1 :20 
1 :25 
1:30 
1:35 
1 :40 
1 :50 
1 :60 
1:70 
E 1 1 h r .  : t 37OC 
1 
1 
+Sensitized sheep red blood cells; i. e. , 
equal volumes of hemolysin (2 units) and 2% sheep RBC's 
combined and reacted for  15 minutes @ 37OC. 
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C. Diagnostic Complement Titration Test 
1. The test antiserum is serially diluted* (with appropriate two-fold 
dilutions) using the Microtitcr 25 p1 Microdiluters; make six 
such dilutions. 
2.  TO each ser ia l  dilution antiserum well is added 25 p1 of the 
test  antigen (2 units) and 50 p1 of complement (2 units). 
3 .  Wells 7 ,  8, and 9 contain the first three antiserum dilutions 
. wit5out the added antigen. 
4. Well 10 contains antigen without antiserum. 
5. Wells 11 and 12 contain no antigen and no antiserum. 
6. Mix gently and incubate for 18 hours a t  6-8OC. 
refrigerator and incubate at 37 C for 15 minutes. 
Remove from 
0 
7. Mix equal amounts (by volumes) of 2 units of hemolysin and 
a 271 suspension of freshly-prepared sheep red blood cells. 
React for 15 minutes a t  room temperature, then add 50 p1 to 
each of the first  eleven wells. To the 12th well add 25 p1 of 
sheep cells without hemolysin. 
8. Mix and incubate for 30 minutes a t  37OC. 
9. Read for cell lysis.  I 
./# 
:%All diluent is  composed of Verona1 buffer containing 0.02% gelatin. 
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W e l l  
No. 
6 
7 
8 
9 
10 
1 1  
12 
DIAGNOSTIC COMPLEMENT TITRATION TEST 
Antiserum Antigen, 2 units 
( p l )  (dilution) (p1) 
25 
25 
25 
25 
25 
25 
25 
25 
25 
0 
0 
0 
1 :4 
1:8 
1: 16 
1:32 
1:64 
1: 128 
1 :4 
1 :8 
1:16 
25 
25 
25 
25 
25 
25 
0 
0 
0 
0 
25 
0 
Complement Diluent 
2 units (pl) (pl) 
50 0 
50 0 
50 0 
50 0 
50 0 
50 0 
50  25 
50 25 
50 25 
50 25 
50 50 
50 75 
Sensitized 
RBC's 2 units 
hemolysin t 2% 
Incubate sheep cells (11.1; 
18 hrs.o 50 
at 6O-8 C 50 
Then 15 
min. at 
3 7%. 
50 
50 
50 
50 
50 
50 
50 
50 
50 
24 (w/o 
hemolysin) 
All reagents are  made o r  diluted in Verona1 buffer containing . 02% gelatin. 
standard Micro-titer is used with disposable titer plates (u-plates) and disposable 
Micropipettes. 
A 
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STEP 1 
1. 
2.  1 
3,  
4. 
5 .  
6. 
GLOBULIN ISOLATION 
VIA 1/  2 AMMONIUM SULFATE PRECIPITATION 
Dilute serum in an equal amount of saturated (NH4)2S04. 
saturated salt i s  added drop by drop, st irring lightly while adding 
The 
at 4 O C .  
Store overnight , at ~ O C .  
After 21-24 hours centrifuge the mixture at 10,000 rpm for 15 minutes. 
Decant the supernate (but save f o r  further precipitatiqn, if needed). 
Resuspend precipitate in a minimal amount of saline. 
Dialyze against phosphate buffered saline, pH 8.2, for 24 hours. + 
% Alternate Method: 
Dialyze f o r  2 hours against running tap water, then dialyze against 
glycine buffer overnight. 
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STEP 2 
( 1 / 3  AMMONIUM SULFATE PRECIPITATION) 
GLOBULIN ISOLATION VIA 
1. 
a total of 25 ml saturated ammonium sulfate solution, thus effecting one-third 
saturation. 
solution until all precipitate from the previous addition has dissolved. Eventually 
the precipitate persists. 
samples of antiserum are to be fractionated, a pH of 7.8 
With constant stirring, slowly add (dropwise) to a 50 ml  serum sample 
During the f i rs t  stages, do not proceed with the addition of the salt 
Continue adding the salt solution slowly. (When large 
should be maintained 
)at all times during the precipitation procedure. Constant maintenance of the pH 
is not necessary with amounts below 50 ml. ) 
2. 
just the pH of the suspension to 7 . 8  with 2 - N NaOH. 
with weak alkali ( 0 . 3  to 1.0 - N) and large samples, 100 ml  o r  more,  with stronger 
alkali (4.0 to 5. 0 - N). 
local excess of alkali with subsequent denaturation of the protein, while the use 
of weak alkali on large samples may dilute the system to the point where gamma 
globulin will begin to dissolve. 
Upon completion of the addition of the ammonium sulfate solution, ad- 
Small samples a r e  adjusted 
The use of strong alkali on small samples may result in 
3 .  
avoid mechanical trapping of serum components other than gamma globulin in 
the precipitate; le t  stand overnight 4OC. 
Continue stirring the suspension for an additional 2 hours in order to 
4. 
with a rotating radius of 14 cm). 
Centrifuge the suspension for 30 min. at 1400 xg. (about 3000 rpm 
5. 
original serum sample. 
6 .  
against PBS, pH 8.2,  for several days a t  4OC. 
checking for ammonium ions, by the addition of a few drops of Nessler's reagent. 
Dissolve the precipitate in enough saline to restore the volume of the 
Remove the ammonium sulfate from the precipitate by dialyzing 
Change the dialysate twice daily 
7. 
trifuge the solution at 4OC for 30 min. a t  1400 xg. 
usually f o h s  during dialysis. 
8. 
method. ' 
After dialysis is complete remove the solution from the tubing. Cen- 
Some insoluble material 
The final solution will be slightly opalascent. 
&heck the product for yield of antibody protein, using any conventional 
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i APPENDIX €3 
PIA TEST PROCEDURE 
AND 
BEAD AGGLUTINATION ANALYSIS 
1 .  
2 .  
3 .  
5. 
6 .  
PASSIVE IMMUNO AGGLUTINATION (PIA) PROTOCOL 
9 Mix .05 ml of 3 x 10 /ml  sensitized polystyrene latex heads (1. l p ) .  
diameter) with .05 ml of the appropriate antigen suspension. 
Mix  by shaking. 
Incubate in a water bath for  60 minutes at 4OoC. 
Place an aliquot of the mixture on a slide and cover with a 
cover slip. 
Inspect six randomly selected fields under a microscope and 
record clump size distribution in each field. 
Take clump size distribution of six fields and perform bead 
agglutination analysis. 
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BEAD AGGLUTINATION ANALYSIS 
The mean number of beads in the clumps i s  a pertinent measure of 
bead agglutination. A method of determining this parameter is presented be- 
low. 
A dominant characteristic of bead agglutination i s  the mean clump 
size, or  group size. In practice, i t  is usually not practical to take all the 
data required to exactly determine the mean clump size, so  that an approxi- 
mation method i s  required. 
1 
Define a few pertinent parameters: 
G 
N The total number of clumps, all sizes 
The number of particles in a given clump 
The observed number of clumps of size G = j 'j 
p(G) The probable number of clumps of size G 
P(>G)The probable number of clumps la rger  than G 
M(>G)The total number of particles i n  clumps larger  than G 
AN( >G)The number of clumps larger than G 
A few relations follow immediately: 
m 
N = C  qj 
j = l  
P ( > O )  = 1.0 
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- 
G =  
Also, the probabilities p(G) are normalized such that 
5 p(Gj) = N 
j = l  
Thus the total number of particles (beads) in all clumps is 
m m 
1 
i 
J 
M = N e  = G . P ( G . )  = j q j  
j=1 J J j= l  
(4) 
(Xote that Gj G j.) 
- 
The parameter of most basic interest i s  the mean clump size, G. 
In principle, may be experimentally determined from Equation 3 .  Howex-er, 
in practice i t  i s  difficult or  impossible to accurately determine the sizes of the 
very large clumps (e. g., G > 10). Therefore i t  will be necessary to choose 
a statistical model to approximately describe the distribution of large clumps. 
Suppose, for example, the clump sizes were randomly (Poisson) 
- 
distributed, having mean clump size G = G. Then 
- - 
-G -G G c  
G! G!  
-G -m 
- 1 m e  iq P(G) = 
The percent of clumps of size greater than G will be 
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O r ,  counting beads, the percent of bcads in clumps of size greater 
wi l l  be 
than G 
(5c) 
Equations 5b and 5c a r e  shown in Figures 1 an2 2 for selected values of the 
mean clump size G = m .  
- - 
If the clumps were Poisson distributed in size Figure 1 illustrates 
that counting the number of clumps >G might be an unsatisfactory criterion. 
1 If the mean size were as  small a s  3.0 the number of clumps greater than, say 
8 beads, i s  expected to be less  than 1 %. 
over five times a s  large - the probability i s  over 97%. 
region would be greatly enhanced. 
Yet for a mean size of 16.0 - just 
The sensitivity in this 
But the scale would be non-linear, and the 
dynamic range would be limited. 
A different probability 
described by 
G P ( > G )  = N (1 - - ) a  
Ga 
This implies 
a , G I G  P(G) = - Ga 
N 
distribution has been tentatively selected, 
(6a) a G <,G 
For this distribution the mean clump size, E ,  i s  approximately 
a - a j=1 a -   G [ ( G a t k r  -($,"I G N a 
G 
c J F  
Ga N 
j=1 C Ga 
-  - 
N 2 G =  - 
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., -- 
The total number of particles in clumps greater than size G is expected 
to be 
M ( > G )  = 2 G j p ( G j )  
j=Gt l  
G 
j = l  
= M - C G j  p (Gj) 
Assume an experiment in which the number of clumps, 7) ., in 
A J  
each size group has been accurately counted up to same size G = G, 
total number of clumps AN, greater than size G have also been counted. If 
from this data the parameter Ga can be estimated, then (using Equation 6d) 
the mean clump size G can be approximately determined. 
and the 
A .  
- 
If in Equation 6a the experimentally determined AN (7G) i s  substi- 
tuted for P (>G), then it can be solved for G in t e r m s  of the known param- 
eters  G, N,  and AN: 
a A 
A 
(7)  
G 
1 - -  AN N 
G =  a 
- 
Finally, G is calculated from Equations 3 and 6D 
c 
G . 7  
N -  N ' N  
- M - J=1 3 M(>G) G =  
A 
G 
where Ga is determined from Equation 7. 
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Current evaluation of the data is performed on an XDS 940 
computer through a time sharing linkup. 
the data is written in standard Fortran IV  language. 
the number and size of clumps counted in each of the six fields and 
determines the mean clump size. 
necessary calculations but prints out the appropriate tables and cor- 
responding graphs resulting in a considerable savings in time shown 
(as  examples) in Tables 1 and 2 and Figure 1. The calculations per- 
formed by the program to  determine the mean clump size a r e  derived from 
The program for processing 
This program takes 
This program not only performs the 
he general formula shown in 1 and 2. This formula represefits a refine- 
ment of the steps used in the program on the Olivetti 101. 
a 
G 
- 
2 . )  G 
G 
= X axis Intercept 
- - G (G t 1) 
P - (+ P 
A N (  -333 6) 
N "i where p - 2 
= corrected mean clump size 
